WO2012038914A2 - Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants - Google Patents

Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants Download PDF

Info

Publication number
WO2012038914A2
WO2012038914A2 PCT/IB2011/054157 IB2011054157W WO2012038914A2 WO 2012038914 A2 WO2012038914 A2 WO 2012038914A2 IB 2011054157 W IB2011054157 W IB 2011054157W WO 2012038914 A2 WO2012038914 A2 WO 2012038914A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
surfactant
antimicrobial
alkyl
foam
Prior art date
Application number
PCT/IB2011/054157
Other languages
French (fr)
Other versions
WO2012038914A3 (en
Inventor
Angela R. Eder
Daniel E. Pedersen
Charles A. Hodge
Original Assignee
Ecolab Usa Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecolab Usa Inc. filed Critical Ecolab Usa Inc.
Priority to CN201180045325.6A priority Critical patent/CN103118655B/en
Priority to JP2013528829A priority patent/JP5990174B2/en
Priority to BR112013006096-4A priority patent/BR112013006096B1/en
Priority to MX2013003141A priority patent/MX2013003141A/en
Priority to EP11826498.5A priority patent/EP2618806B1/en
Publication of WO2012038914A2 publication Critical patent/WO2012038914A2/en
Publication of WO2012038914A3 publication Critical patent/WO2012038914A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16Foams
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/12Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44Guanidine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/604Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/62Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/662Carbohydrates or derivatives
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/75Amino oxides
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/835Mixtures of non-ionic with cationic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/94Mixtures with anionic, cationic or non-ionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/30Amines; Substituted amines ; Quaternized amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients

Definitions

  • the present invention is directed to antimicrobial compositions, like personal care compositions, having improved antimicrobial effectiveness and high foaming attributes. More particularly, the present invention relates to antimicrobial compositions exhibiting the antimicrobial effectiveness of cationic active ingredients and a polyquaternary functionalized alkyl polyglucoside or a quaternary functionalized alkyl polyglucoside, with optional properties of a broad spectrum of antimicrobial efficacy, high foam and reduced irritation to mammalian tissue.
  • Antimicrobial personal care compositions are known in the art. Especially useful are antimicrobial cleansing compositions, which typically are used to cleanse the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user.
  • Antimicrobial compositions are used, for example, in the health care industry; long term care, hospitality and health / exercise facilities; food service industry, meat processing industry, and in the private sector by individual consumers.
  • the widespread use of antimicrobial compositions indicates the importance consumers place on controlling bacteria and other microorganism populations on skin. It is important, however, that antimicrobial populations provide a substantial and broad spectrum reduction in microorganism populations quickly and without problems associated with toxicity and skin irritation.
  • antimicrobial cleansing compositions typically contain an active antimicrobial agent, an anionic surfactant for cleansing and foam generation, skin conditioning agents for cosmetic effects, and dyes, perfumes, and optional thickening agents, such as clays, polymers, cellulosic derivatives, or colloids, for aesthetic effects, all in an aqueous carrier.
  • active ingredients selected from the following classes: phenolic compounds, carbanalide compounds, lower alcohols, surface active agents halogens, and carboxylic acids. Each of these classes has their own unique advantages and challenges.
  • Triclosan is the dominant antimicrobial active ingredient in the dermal cleanser market.
  • Triclosan is disfavored as an antimicrobial agent due to environmental persistence and health concerns due to the possible formation of intermediate and/or environmental by products.
  • a need exists for an efficacious antimicrobial personal care composition which is substantially free of biocides such as Triclocarban and Triclosan but that still provides a high foam level desired by consumers and is mild to the skin.
  • the present invention is directed to such antimicrobial compositions.
  • an antimicrobial composition that exhibits fast efficacy and high foaming attributes.
  • the antimicrobial composition comprises a cationic active ingredient, a quaternized sugar-derived surfactant, a foam boosting surfactant which may encompass nonionic surfactants, amphoteric surfactants, cationic surfactants, anionic surfactants and water.
  • the present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4' -trichloro-2'hydroxy-diphenylether), have a high cidal activity in a short amount of time, provide stable copious foam and may optionally contain ingredients to increase skin compatibility and skin health.
  • one aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue, the antimicrobial composition comprising: (a) about 0.3 wt.% to about 6.0 wt. , by weight of cationic actives; (b) about 0.1 wt.% to about 18 wt.%, by weight, of a quaternized sugar-derived surfactant; (c) about 0.1 wt.% to about 40 wt.%, by weight of a foam boosting surfactant; (d) about 1 wt.% to about 25 wt.% dermal adjuvants and (e) water or other suitable diluent.
  • one aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue, wherein the composition has a relative weight ratio of cationic active to quaternized sugar surfactant to foam boosting surfactant from about 1:0.2:0.2 to about 1:3:8.
  • Another aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue which is stable and has a pH of about 4.0 to about 9.0.
  • the present composition also exhibits excellent esthetic properties, such as copious foam and foam stability and may optionally contain ingredients to increase skin compatibility and skin health. Moreover, the composition may exhibit reduced tissue irritancy potential.
  • a further aspect of the present invention is to provide personal use products based on an antimicrobial composition of the present invention, for example, a skin cleanser, a surgical scrub, a hand sanitizer gel, a disinfectant, antiseptic wash, and the like.
  • a further aspect of the present invention is to provide a method of reducing Gram positive and/or Gram negative bacteria populations on mammalian tissue, including human tissue, by contacting the tissue, like the dermis, with a composition of the present invention for a sufficient time, such as about 30 seconds to 5 minutes, to reduce the bacteria level to a desired level.
  • Antimicrobial efficacy is applicable to viral and fungal organisms as well as Gram positive and Gram negative bacteria.
  • FIG . 1 illustrates a graph depicting the tests results of the efficacy following a 30 second exposure time of three different cationic active ingredients, specifically, 0.5 % quat (benzalkonium chloride), 2% CHG (chlorhexidine gluconate), and 1% PHMB (polyhexamethylene biguanide) in a representative surfactant system.
  • 0.5 % quat benzalkonium chloride
  • CHG chlorhexidine gluconate
  • PHMB polyhexamethylene biguanide
  • FIG. 2 illustrates a graph depicting the test results of the efficacy against S. aureus and E. coli bacteria with increased concentrations of quaternary sugar-derived surfactants, specifically, poly (trimomumhydroxypropyl cocogluocosides chloride).
  • quaternary sugar-derived surfactants specifically, poly (trimomumhydroxypropyl cocogluocosides chloride).
  • FIG. 3 illustrates a graph depicting the test results of the efficacy with increased concentrations of foam boosting surfactants, specifically, amine oxide.
  • foam boosting surfactants specifically, amine oxide.
  • FIG. 4 illustrates the dermal irritancy (mildness) of the preferred
  • an antimicrobial dermal cleanser to four commercially available antimicrobial soaps.
  • FIG. 5 illustrates the foam profile of the preferred embodiment for an antimicrobial dermal cleanser to three commercially available antimicrobial soaps.
  • FIG. 6 illustrates the efficacy against S. aureus and E. coli bacteria following a 30 second exposure to a cationic active in combination with quaternary sugar-derived surfactants, held constant at 1.25% and an n-alkyl (C 12-16 ) dimethylamine oxide foam boosting surfactant.
  • FIG. 7 illustrates the foam rigidity of the preferred embodiment for an antimicrobial dermal cleanser to two commercially available antimicrobial soaps with cationic actives.
  • weight percent (wt-%), percent by weight, % by weight, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the total weight of the composition and multiplied by 100.
  • the term "about" modifying the quantity of an ingredient in the compositions of the invention or employed in the methods of the invention refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the real world; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of the ingredients employed to make the
  • compositions or carry out the methods are or carry out the methods; and the like.
  • the term about also encompasses amounts that differ due to different equilibrium conditions for a composition resulting from a particular initial mixture. Whether or not modified by the term "about,” the claims include equivalents to the quantities.
  • cationic active is defined as the ingredient that provides antimicrobial cidal activity.
  • skin care active is defined as the ingredient or ingredients that improve or maintain the health of the dermal barrier.
  • alkyl refers to a straight or branched chain monovalent hydrocarbon radical having a specified number of carbon atoms. As used herein, “alkyl” refer to a linear or branched C 6 -Ci 8 carbon chain.
  • microbial or "microbial population” refers to bacterial, fungal, yeast, or viral population or combinations thereof or any mixture thereof in a laboratory or natural setting.
  • surfactant or "surface active agent” refers to an organic chemical that when added to a liquid changes the properties of that liquid at a surface or interface.
  • Croning means to perform or aid in soil removal, bleaching, microbial population reduction, rinsing, or combination thereof.
  • the term "substantially free” refers to compositions completely lacking the component or having such a small amount of the component that the component does not affect the effectiveness of the composition.
  • the component may be present as an impurity or as a contaminant and shall be less than 0.5 wt. .
  • the amount of the component is less than 0.1 wt. % and in yet another embodiment, the amount of component is less than 0.01 wt. .
  • actives or “percent actives” or “percent by weight actives” or “actives concentration” are used interchangeably herein and refers to the concentration of those ingredients involved in cleansing expressed as a percentage minus inert ingredients usch as water or salts.
  • triclosan free or “free of triclosan” refers to a composition, mixture, or ingredients that do not contain triclosan (2,4,4' -trichloro- 2'hydroxy-diphenylether) or triclosan containing compounds or to which the same has not been added. Should triclosan or triclosan containing compounds be present through contamination of a composition, mixture, or ingredients, the amount of the same shall be less than 0.5 wt. . In another embodiment, the amount of is less than 0.1 wt. % and in yet another embodiment, the amount is less than 0.01 wt. .
  • Antimicrobial Compositions Containing Cationic Active Compounds and Quaternized Sugar Derived Surfactants
  • the present invention relates to an antimicrobial composition that exhibits fast efficacy and high foaming attributes.
  • the antimicrobial composition comprises a cationic active ingredient, a quaternized sugar-derived surfactant, a foam boosting surfactant which may encompass anionic surfactants, nonionic surfactants, amphoteric surfactants, or cationic surfactants and water.
  • the present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4'-trichloro-2'hydroxy- diphenylether),have a high cidal activity in a short amount of time, provide stable copious foam and may optionally contain ingredients to increase skin compatibility and skin health.
  • an antimicrobial composition for reducing microbial population on dermal tissue includes: (a) about 0.3 wt.% to about 6.0 wt. , by weight of cationic actives; (b) about 0.1 wt.% to about 18 wt.%, by weight, of a quaternized sugar-derived surfactant; (c) about 0.1 wt.% to about 40 wt.%, by weight of a foam boosting surfactant; (d) about 1 wt.% to about 25 wt.% dermal adjuvants and (e) water or other suitable diluent.
  • the relative weight ratio of cationic active ingredient to quaternized sugar surfactant to foam boosting surfactant is from about 1:0.2:0.2 to about 1:3:8.
  • Another aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue which is stable and has a pH of about 5.0 to about 8.0.
  • the present composition also surprisingly exhibits excellent esthetic properties, such as copious foam and foam stability and may optionally contain ingredients to increase skin compatibility and skin health. Moreover, the composition may exhibit reduced tissue irritancy potential.
  • a further aspect of the present invention is to provide personal use products based on an antimicrobial composition of the present invention, for example, a skin cleanser, a surgical scrub, a hand sanitizer gel, a disinfectant, and the like.
  • a further aspect of the present invention is to provide a method of reducing Gram positive and/or Gram negative bacteria populations on mammalian tissue, including human tissue, by contacting the tissue, like the dermis, with a composition of the present invention for a sufficient time, such as about 30 seconds to 5 minutes, to reduce the bacteria level to a desired level.
  • a cationic active is present in an antimicrobial composition for reducing microbial population on the dermal tissue of a mammal of the present invention in an amount of about 0.3 wt. % to about 6.0 wt. %, and preferably about 0.5 wt. % to about 5.0 wt.%, by weight of the composition.
  • the amount of antimicrobial agent in the composition is related to the end use of the composition, the amount of quaternized sugar-derived surfactant and foam boosting surfactant in the composition, and the presence of optional ingredients in the composition.
  • the amount of antimicrobial agent is sufficient to achieve a microbial kill in a short contact time, for example, 15 to 30 seconds.
  • Cationic active ingredients are an antimicrobial agent useful in the present invention.
  • the cationic or cationically-active ingredients are substances based on nitrogen centered cationic moieties with net positive change.
  • the cationic or cationically-active ingredients are preferably selected from the group consisting of cationic polymers, cationic surfactants, cationic monomers, cationic silicon compounds, cationic derivatized protein hydrolyzates and betaine with at least one cationic or cationically-active group.
  • Suitable cationic active ingredients contain quaternary ammonium groups. Suitable cationic active ingredients especially include those of the general formula:
  • R 1 R 2 R 3 R 4 X (-) wherein R 1 , R 2 , R 3 and R 4 independently of each other represent alkyl groups, aliphatic groups, aromatic groups, alkoxy groups, polyoxyalkylene groups, alkylamido groups, hydroxyalkyl groups, aryl groups, H + ions, each with from 1 to 22 carbon atoms, with the provison that at least one of the groups R 1 , R 2 , R 3 and R 4 has at least eight carbon atoms and wherein X(-) represents an anion, for example, a halogen, acetate, phosphate, nitrate or alkyl sulfate, preferably a chloride.
  • the aliphatic groups can also contain cross-linking or other groups, for example additional amino groups, in addition to the carbon and hydrogen atoms.
  • Particular cationic active ingredients include, for example, but are not limited to, alkyl dimethyl benzyl ammonium chloride (ADBAC), alkyl dimethyl ethylbenzyl ammonium chloride, dialkyl dimethyl ammonium chloride, benzethonium chloride, N, N-bis-(3-aminopropyl) dodecylamine, chlorhexidine gluconate, PHMB (polyhexamethylene biguanide), salt of a biguanide, a substituted biguanide derivative, an organic salt of a quaternary ammonium containing compound or an inorganic salt of a quaternary ammonium containing compound or mixtures thereof.
  • ADBAC alkyl dimethyl benzyl ammonium chloride
  • alkyl dimethyl ethylbenzyl ammonium chloride dialkyl dimethyl ammonium chloride
  • benzethonium chloride N, N-bis-(3-aminopropyl)
  • a present antimicrobial composition is substantially free of triclosan.
  • the phrase "substantially free" of triclosan is defined as meaning that the composition contains 0% to about 0.25% by weight, in total, of triclosan.
  • triclosan may be present in an antimicrobial composition in a total amount of 0.25% or less either as a by-product or as a component of an ingredient in the composition, but triclosan is not intentionally introduced into the composition.
  • Triclosan is disfavored as an antimicrobial agent due to environmental and health concerns due to the possible formation of intermediate and/or environmental by products.
  • the present antimicrobial composition for reducing microbial population on the dermal tissue of a mammal of the present invention also contains a quaternized sugar-derived surfactant.
  • the quaternized sugar- derived surfactant is present in an amount of about 0.1% to about 18%, and preferably about 0.25% to about 12.5%, by weight, of the composition.
  • the amount of quaternized sugar-derived surfactant present in the composition is related to the amount of the cationic active in the composition, to the identity of the quaternized sugar-derived surfactant, and the end use of the composition.
  • the quaternized sugar-derived surfactant is a quaternized alkyl
  • polyglucoside or a polyquaternized alkyl polyglucoside, and the like.
  • the antimicrobial composition of the present invention includes a polyquaternary functionalized alkyl polyglucoside, a cationic active ingredient, water, and an optional foam boosting surfactant.
  • the poly quaternary functionalized alkyl polyglucoside is a cationic surfactant naturally derived from alkyl polyglucosides and has a sugar backbone.
  • Poly quaternary alkyl polyglucosides have the following representative formula:
  • R is an alkyl group having from about 6 to about 22 carbon atoms and n is an integer ranging from 4 to 6.
  • suitable poly quaternary functionalized alkyl polyglucosides components which can be used in the cleansing compositions according to the present invention include those in which the R alkyl moiety contains from about 8 to about 12-carbon atoms. In a preferred embodiment the quaternary functionalized alkyl polyglucoside contains primarily about 10-12 carbon atoms.
  • Examples of commercially suitable poly quaternary functionalized alkyl polyglucosides useful in cleansing compositions of the present invention include but is not limited to: Poly Suga Quat series of quaternary functionalized alkyl polyglucosides, available from Colonial Chemical, Inc., located in South Pittsburg, TN.
  • the antimicrobial composition of the present invention includes a quaternary functionalized alkyl polyglucoside, a cationic active ingredient, water, and an optional foam boosting surfactant.
  • a quaternary functionalized alkyl polyglucoside a cationic active ingredient
  • water a cationic active ingredient
  • an optional foam boosting surfactant a foam boosting surfactant
  • functionalized alkyl polyglucoside is a naturally derived cationic surfactant from alkyl polyglucosides and has a sugar backbone.
  • Quaternary functionalized alkyl is a naturally derived cationic surfactant from alkyl polyglucosides and has a sugar backbone.
  • polyglucosides have the following representative formula:
  • Ri is an alkyl group having from about 6 to about 22 carbon atoms
  • R 2 is CH 3 (CH 2 where n' is an integer ranging from 0-21.
  • suitable quaternary functionalized alkyl polyglucosides components which can be used in the cleansing compositions according to the present invention include those in which the Ri alkyl moiety contains primarily about 10-12 carbon atoms, the R 2 group is C3 ⁇ 4 and n is the degree of polymerization of 1 -2.
  • quaternary functionalized alkyl polyglucoside examples include, but are not limited to, the antimicrobial and antifungal quaternary functionalized alkyl polyglucosides described in United States Patent numbers 7,084,129 and 7,507,399 the disclosures of which are hereby incorporated by reference. Examples of commercially suitable quaternary
  • functionalized alkyl polyglucosides useful in cleansing compositions of the present invention include but is not limited to: Suga Quat TM 1212 (primarily Ci 2 quaternary functionalized alkyl polyglucoside), Suga Quat L 1210 (primarily Ci 2 quaternary functionalized alkyl polyglucoside), and Suga Quat S 1218 (primarily Ci 2 quaternary functionalized alkyl polyglucoside) available from Colonial Chemical, Inc., located in South Pittsburg, TN.
  • the present antimicrobial composition for reducing microbial population on the dermal tissue of a mammal of the present invention also contains a foam boosting surfactant.
  • the foam booting surfactant is present in an amount of about 0.02% to about 10.0%, and preferably about 2% to about 6%, by weight, of the composition.
  • the amount of foam boosting surfactant present in the composition is related to the amount of the cationic active in the composition, the amount of the quaternized sugar-derived surfactant in the composition, the identity of the foam boosting surfactant, and the end use of the composition.
  • the foam-boosting co-surfactant can be (a) nonionic surfactants, (b) amphoteric surfactants, (c) cationic surfactants, (d) anionic surfactants and the like, or (e) mixtures thereof.
  • non ionic foam-boosting co-surfactants include, but are not limited to, alkyl amine oxide, alkyl ether amine oxide, alkyl alcohol alkoxylates, aryl alcohol alkoxylates, substituted alcohol alkoxylates, block nonionic copolymers, heteric nonionic copolymers, alkanolamides, substituted amides, or polyethoxylated glycerol derivatives.
  • the antimicrobial composition can contain a nonionic surfactant component that includes a detersive amount of nonionic surfactant or a mixture of nonionic surfactants.
  • a nonionic surfactant has a hydrophobic region, such as a long chain alkyl group or an alkylated aryl group, and a hydrophilic group comprising an ethoxy and/or other hydrophilic moieties.
  • a "nonionic foam-boosting co-surfactant" has a hydrophobic region having an alkyl group containing six to eighteen carbon atoms, and an average of one to about twenty ethoxy and/or propoxy moieties.
  • non ionic foam-boosting co-surfactants include, but are not limited to, alkyl amine oxide, alkyl ether amine oxide, alkyl alcohol alkoxylates, aryl alcohol alkoxylates, substituted alcohol alkoxylates, block nonionic copolymers, heteric nonionic copolymers, alkanolamides, or polyethoxylated glycerol esters, and mixtures thereof.
  • Numerous other nonionic surfactants are disclosed in McCutcheon's Detergents and Emulsifiers, 1993 Annuals, published by McCutcheon Division, MC Publishing Co., Glen Rock, N.J., pp. 1-246 and 266-273; in the CTFA International Cosmetic Ingredient Dictionary, Fourth Ed., Cosmetic, Toiletry and Fragrance
  • CTFA Dictionary at pages 1- 651 ; and in the CTFA Cosmetic Ingredient Handbook, First Ed., Cosmetic, Toiletry and Fragrance Association, Washington, D.C. (1988) (hereafter the CTFA Handbook), at pages 86-94, each incorporated herein by reference.
  • the antimicrobial composition can contain an amphoteric surfactant component that includes a detersive amount of amphoteric surfactant or a mixture of amphoteric surfactants.
  • Suitable amphoteric surfactants that can ne used include, but are not limited to, imidiazolines and imidiazoline derivatives, isethionates, betaine derivatives, amphoacetate derivatives, propionates, and mixtures thereof.
  • the antimicrobial composition can contain an anionic surfactant component that includes a detersive amount of an anionic surfactant or a mixture of anionic surfactants.
  • the anionic surfactants that can be used according to the invention include any anionic surfactant available in the cleansing industry. Suitable groups of anionic surfactants include sulfonates and sulfates.
  • Suitable surfactants that can be provided in the anionic surfactant component include, but are not limited to, sarcosine derivatives, succinic acid derivatives, carboxylated alcohols, alkyl sulfate and alkyl ether sulfates, sulfonic acid derivatives, diphenyll sulfonate derivatives, alkyl aryl sulfonic acid derivatives, alkyl polyglucoside sulfates or sulfonates.
  • the antimicrobial composition may contain a cationic surfactant component that includes a detersive amount of cationic surfactant or a mixture of cationic surfactants.
  • Cationic surfactants that can be used in the antimicrobial composition include, but are not limited to, quaternized polysaccharides, alkyl polysaccharides, alkoxylated amines, alkoxylated ether amines, phospholipids, phospholipid derivatives, and mixtures thereof.
  • the carrier of the present antimicrobial composition comprises water, propylene glycol, glycerols, alcohols or mixtures thereof. It should be appreciated that the water may be provided as deionized water or as softened water.
  • the water provided as part of the concentrate can be relatively free of hardness. It is expected that the water can be deionized to remove a portion of the dissolved solids. That is, the concentrate can be formulated with water that includes dissolved solids, and can be formulated with water that can be characterized as hard water.
  • the antimicrobial composition of the present invention does not rely upon a low pH or a high pH to provide a rapid reduction in microbial populations.
  • Antimicrobial populations of the present invention have a pH of about 5.0 to about 8.0. Within this pH range, the present compositions effectively reduce microbial populations, and are consumer acceptable, i.e., are mild to the skin, are phase stable, and generate copious, stable foam.
  • the antimicrobial composition can include additional components or agents, such as additional functional materials. As such, in some embodiments, the
  • antimicrobial composition including the cationic active ingredients and quaternary sugar-derived surfactants may provide a large amount, or even all of the total weight of the antimicrobial composition, for example, in embodiments having few or no additional functional materials disposed therein.
  • the functional materials provide desired properties and functionalities to the antimicrobial composition.
  • the term "functional materials" include a material that when dispersed or dissolved in a use and/or concentrate solution, such as an aqueous solution, provides a beneficial property in a particular use.
  • the antimicrobial composition containing the cationic active ingredients and the quaternized sugar-derived surfactants may optionally contain other disinfectants, sanitizers, dyes, thickening or gelling agents, and perfumes.
  • Various dyes, odorants including perfumes, and other aesthetic enhancing agents which are compatible with the invention chemistry may also be included in the antimicrobial composition.
  • Fragrances or perfumes that may be included in the compositions include, for example, terpenoids such as citronellol, aldehyes such as amyl cinnamaldehyde, a jasmine such as CIS-jasmine or jasmal, vanillin, and the like.
  • the present composition can also include any number of adjuvants.
  • adjuvants are present in an amount of about 1% to about 25%, and preferably about 1% to about 15 %, by weight, of the composition.
  • the antimicrobial composition can include glycerin, sorbitol, esters, polyquats, glycols, preservatives, chelators, pH additives, pigments or dyes among any number of other constituents which can be added to the composition.
  • Such adjuvants can be pre- formulated with the present composition or added to the system simultaneously, or even after, the addition of the present composition.
  • the antimicrobial composition can also contain any number of other constituents as necessitated by the application, which are known and which can facilitate the activity of the present invention.
  • the antimicrobial composition of the present invention has a high broad spectrum of antimicrobial efficacy, high foam and reduced irritation to mammalian tissue. Exemplary compositions are provided in the following tables.
  • Adjuvants (Dermal) Polyquats, 1.0 25.0 2.0 10.0
  • Adjuvants (Dermal) 1 .0 25.0 1.75 15.0
  • Adjuvants (Dermal) 1 .0 25.0 2.0 10.0
  • the formula may be available as a ready-to-use or concentrate which would be subsequently diluted to the proper use concentration with water either manually or by suitable equipment or an apparatus.
  • the concentrate composition of the present invention can be provided as a solid, liquid, or gel, or a combination thereof.
  • the cleansing compositions may be provided as a concentrate such that the cleansing composition is substantially free of any added water or the concentrate may contain a nominal amount of water
  • the concentrate can be formulated without any water or can be provided with a relatively small amount of water in order to reduce the expense of transporting the concentrate.
  • the composition concentrate can be provided as a capsule or pellet of compressed powder, solid, or loose powder, either contained by a water soluble material or not.
  • the capsule or pellet of the composition in a material, can be introduced into a volume of water, and if present the water soluble material can solubilize, degrade, or disperse to allow contact of the composition concentrate with the water.
  • the terms "capsule” and "pellet” are used for exemplary purposes and are not intended to limit the delivery mode of the invention to a particular shape.
  • the concentrate When provided as a liquid concentrate composition, the concentrate can be diluted through dispensing equipment using aspirators, peristaltic pumps, gear pumps, mass flow meters, and the like.
  • This liquid concentrate embodiment can also be delivered in bottles, jars, dosing bottles, bottles with dosing caps, and the like.
  • the liquid concentrate composition can be filled into a multi-chambered cartridge insert that is then placed in a spray bottle or other delivery device filled with a pre-measured amount of water.
  • the concentrate composition can be provided in a solid form that resists crumbling or other degradation until placed into a container.
  • a container may either be filled with water before placing the composition concentrate into the container, or it may be filled with water after the composition concentrate is placed into the container.
  • the solid concentrate composition dissolves, solubilizes, or otherwise disintegrates upon contact with water.
  • the solid concentrate composition dissolves rapidly thereby allowing the concentrate composition to become a use composition and further allowing the end user to apply the use composition to a surface in need of cleansing.
  • the cleansing composition is provided as a solid, the compositions provided herein may be altered in a manner to solidify the cleansing composition by any means known in the art.
  • the amount of water may be reduced or additional ingredients may be added to the cleansing composition, such as a solidification agent.
  • the solid concentrate composition can be diluted through dispensing equipment whereby water is sprayed at the solid block forming the use solution. The water flow is delivered at a relatively constant rate using mechanical, electrical, or hydraulic controls and the like.
  • the solid concentrate composition can also be diluted through dispensing equipment whereby water flows around the solid block, creating a use solution as the solid concentrate dissolves.
  • the solid concentrate composition can also be diluted through pellet, tablet, powder and paste dispensers, and the like.
  • Materials used in the described embodiments include, but are not limited to: Stearyldimonium-hydroxypropyl Laurylglucosides Chloride, Cocoglucosides
  • compositions was measured by the time kill method [ASTM E 2315 Standard Guide for Assessment of Antimicrobial Activity Using a Time Kill Procedure], whereby the survival of challenged organisms exposed to an antimicrobial test composition is deterred as a function of time.
  • a diluted aliquot of the composition is brought into contact with a known population of test bacteria for a specified time period at a specified temperature.
  • the test composition is neutralized at the end of the time period, which arrests the antimicrobial activity of the composition.
  • the percent or, alternatively, log reduction from the original bacteria population is calculated.
  • the time kill method is known to those skilled in the art.
  • comparative data on the foam profile of representative systems is shown.
  • composition can be tested at any concentration from 0-100%.
  • concentration to use is at the discretion of the investigator, and suitable concentrations are readily determined by those skilled in the art. All testing if performed in triplicate, the results are combined, and the average log reduction is reported.
  • Any contact time period can be chosen. Typical contact times range from 15 second to 5 minutes, with 30 seconds and 1 minute being typical contact times.
  • the contact temperature also can be any
  • temperature typically room temperature, or about 25 degrees Celsius.
  • the microbial suspension, or test inoculum is prepared by growing a
  • microbial culture on any appropriate solid media (e.g., agar).
  • agar e.g., agar
  • the microbial population then is washed from the agar with sterile
  • physiological saline and the population of the microbial suspension is adjusted to about 10 colony forming units per ml (cfu/ml).
  • S. aureus is a Gram positive bacteria
  • E. coli is a Gram negative bacteria
  • the foam stability was determined by using the difference between the foam/ air interference and the foam/aqueous interface 5 minutes after pouring a 1% solution into a lOOOmL beaker.
  • EpiDerm tissues are conditioned by incubation ot release transport-stress related compounds and debris overnight. After pre-incubation, tissues are topically exposed to the test chemicals for 60 minutes. Preferably, three tissues are used per test chemical (TC) and for the positive control (PC) and negative control (NC). Tissues are then thoroughly rinsed, blotted to remove the test substances, and transferred to fresh medium. Tissues are incubated for 42 hrs.
  • TC test chemical
  • PC positive control
  • NC negative control
  • the MTT assay is performed by transferring the tissues to 24-well plates containing MTT medium (1 mg/mL) after a 3 hr MTT incubation, the blue formazan salt formed by cellular mitochondria is extracted with 2.0 mL/tissue of isopropanol and the optical density of the extracted formazan is determined using a spectrophotometer at 570nm. Relative cell viability is calculated for each tissue as % of the mean of the negative control tissues. Skin irritation potential of the test material is predicted if the remaining relative cell viability is below 50%.
  • the foam resistance was determined by measuring 65 grams of the test product into a blender and blending for about 10 seconds on medium speed. Thereafter, the test solution was poured into a cylinder and a plastic ball was dropped into the test solution and timed to determine how many seconds it took for the plastic ball to drop from a first pre-determined level to a second pre-determined level, e.g., from 100 mL mark on the cylinder to the 40 mL mark on the cylinder.
  • Table 7 illustrates the formulas for the three cationic active ingredient systems tested. Both the quaternary sugar-derived surfactant and foam boosting surfactant were held constant and only the cationic active ingredient was changed between the three tests performed. The results are illustrated in Figure 1.
  • the quaternary sugar-derived surfactant has a high cidal activity against S. aureus and E. coli bacteria after only 30 seconds of exposure. Also, the tolerance of the quaternary sugar derived surfactant against bacteria is shown. Furthermore, it is clearly illustrated that an increased concentration of quaternary sugar-derived surfactant maintains a good log kill of bacteria up until a 1 to 4 ratio of quaternary sugar-derived surfactant to cationic active ingredients.
  • Table 9 and Figure 3 (Log Kill of Foam Boosting Surfactants): Table 15 and Figure 3 illustrate the efficacy with increased concentrations of foam boosting surfactants, specifically, amine oxide.
  • the amount and type of cationic active ingredient (0.5% ADBAC Quat) and Quaternary sugar-derived surfactant (1.25 % Poly
  • the foam boosting surfactant has a high cidal activity against S. aureus and E. coli bacteria after only 30 seconds of exposure. Also, the tolerance of the foam boosting surfactant against bacteria is shown. Furthermore, it is clearly illustrated that a broad range of foam boosting surfactant maintains a good log kill of bacteria.
  • Embodiment Applicants tested the dermal irritancy (mildness) of the preferred embodiment for an antimicrobial Dermal Cleanser as illustrated in Table 12 to four commercially available antimicrobial soaps.
  • Commercially Available Products A, C and D are available by Gojo Medicated, Akron, Ohio and Commercially Available Product B is available by Dial a subsidiary of Henkel Corporation, Dusseldorf, Germany.
  • the antimicrobial dermal cleanser of the current invention has a high relative mildness index especially in comparison to antimicrobial hand soaps that are commercially available.
  • Figure 5 (Foam Profile for an Antimicrobial Dermal Cleanser Embodiment): Applicants tested the foam profile of the preferred embodiment for an antimicrobial Dermal Cleanser as illustrated in Table 12 to three commercially available antimicrobial soaps. As illustrated in Figure 6, the antimicrobial dermal cleanser of the current invention has both good foam volume and foam stability especially in comparison to antimicrobial hand soaps that are commercially available.
  • Table 10 and Figure 6 (Efficacy of Cationic Actives in Combination with Quaternary Sugar Derived Surfactants and Alkyl Dimethyl Amine Oxide): Applicants tested the efficacy against S. aureus and E. coli bacteria with various quaternary sugar- derived surfactants, held constant at 1.25%. The amount and type of cationic active ingredient (0.5% ADBAC Quat) and foam boosting surfactant (1.95% Alkyl Dimethyl Amine Oxide) was held constant.
  • Table 1 1 and Figure 7 Comparative Foam Rigidity: Applicants tested the foam rigidity of an embodiment of the current invention for use in dermal applications as shown below in Table 1 1 in comparison to two commercially available products, Commercial Products E and F.
  • Commercial Products E and F are traditional anionic surfactant base dermal washes containing a cationic active.
  • Commercial Product E is commercially available by Proctor & Gamble, Cincinnati, Ohio and Commercial Product F is commercially available by Deb Group Limited, United Kingdom, England.
  • the results of the foam rigidity test are illustrated in Figure 7. As illustrated in Figure 7, the foam rigidity of the dermal wash of the current invention is greater than
  • Foam Boosting Surfactant 0.5 - 10
  • the antimicrobial compositions of the present invention have several practical end uses, including hand cleansers, surgical scrubs, hand sanitizer gels, and similar personal care products. Additional types of compositions include foamed compositions, such as creams, mousses, and the like.
  • the present antimicrobial compositions can be manufactured as dilute ready-to-use compositions, or as concentrates that are diluted prior to use.

Abstract

The antimicrobial composition of the present invention comprises a cationic active ingredient, a quaternized sugar-derived surfactant, and an optional foam boosting surfactant. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4'-trichloro-2'hydroxy-diphenylether), have a high cidal activity in a short amount of time, provide stable copious foam and exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.

Description

ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS
FIELD OF THE INVENTION
[0001] The present invention is directed to antimicrobial compositions, like personal care compositions, having improved antimicrobial effectiveness and high foaming attributes. More particularly, the present invention relates to antimicrobial compositions exhibiting the antimicrobial effectiveness of cationic active ingredients and a polyquaternary functionalized alkyl polyglucoside or a quaternary functionalized alkyl polyglucoside, with optional properties of a broad spectrum of antimicrobial efficacy, high foam and reduced irritation to mammalian tissue.
BACKGROUND
[0002] Antimicrobial personal care compositions are known in the art. Especially useful are antimicrobial cleansing compositions, which typically are used to cleanse the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user.
[0003] Antimicrobial compositions are used, for example, in the health care industry; long term care, hospitality and health / exercise facilities; food service industry, meat processing industry, and in the private sector by individual consumers. The widespread use of antimicrobial compositions indicates the importance consumers place on controlling bacteria and other microorganism populations on skin. It is important, however, that antimicrobial populations provide a substantial and broad spectrum reduction in microorganism populations quickly and without problems associated with toxicity and skin irritation.
[0004] In particular, antimicrobial cleansing compositions typically contain an active antimicrobial agent, an anionic surfactant for cleansing and foam generation, skin conditioning agents for cosmetic effects, and dyes, perfumes, and optional thickening agents, such as clays, polymers, cellulosic derivatives, or colloids, for aesthetic effects, all in an aqueous carrier. [0005] Several different classes of antimicrobial agents have been used in antimicrobial cleansing compositions. These include active ingredients selected from the following classes: phenolic compounds, carbanalide compounds, lower alcohols, surface active agents halogens, and carboxylic acids. Each of these classes has their own unique advantages and challenges. Examples of specific antimicrobial agents include PCMX (para-chlorometa xylenol), Triclosan, Triclocarban, benzyl alcohol, quaternary ammonium compounds (QAC), iodine and iodine complexes and biguanides (e.g., chlorhexidine digluconate). At this time Triclosan is the dominant antimicrobial active ingredient in the dermal cleanser market.
[0006] Although there is an increasing consumer demand for products which have both an activity against bacteria and other microorganisms, there is an even greater demand to fulfill the consumer's expectations with regard to their level of concern with certain biocides such as Triclocarban and Triclosan.
[0007] Triclosan is disfavored as an antimicrobial agent due to environmental persistence and health concerns due to the possible formation of intermediate and/or environmental by products. Thus, a need exists for an efficacious antimicrobial personal care composition which is substantially free of biocides such as Triclocarban and Triclosan but that still provides a high foam level desired by consumers and is mild to the skin. The present invention is directed to such antimicrobial compositions.
[0008] The above-mentioned disadvantages of current antimicrobial compositions are addressed by embodiments of the present invention and will be understood by reading and studying the following specification. The following summary is made by way of example and not by way of limitation. It is merely provided to aid the reader in understanding some of the aspects of the invention.
SUMMARY OF THE INVENTION
[0009] The summary of the invention is intended to introduce the reader to various exemplary aspects of the invention. Particular aspects of the invention are shown in other sections herein below, and the invention is set forth in the appended claims which alone demarcate its scope.
[0010] In accordance with an exemplary embodiment of the present invention, an antimicrobial composition that exhibits fast efficacy and high foaming attributes is provided. The antimicrobial composition comprises a cationic active ingredient, a quaternized sugar-derived surfactant, a foam boosting surfactant which may encompass nonionic surfactants, amphoteric surfactants, cationic surfactants, anionic surfactants and water. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4' -trichloro-2'hydroxy-diphenylether), have a high cidal activity in a short amount of time, provide stable copious foam and may optionally contain ingredients to increase skin compatibility and skin health.
[0011] Accordingly, one aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue, the antimicrobial composition comprising: (a) about 0.3 wt.% to about 6.0 wt. , by weight of cationic actives; (b) about 0.1 wt.% to about 18 wt.%, by weight, of a quaternized sugar-derived surfactant; (c) about 0.1 wt.% to about 40 wt.%, by weight of a foam boosting surfactant; (d) about 1 wt.% to about 25 wt.% dermal adjuvants and (e) water or other suitable diluent.
[0012] Additionally, one aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue, wherein the composition has a relative weight ratio of cationic active to quaternized sugar surfactant to foam boosting surfactant from about 1:0.2:0.2 to about 1:3:8.
[0013] Another aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue which is stable and has a pH of about 4.0 to about 9.0. The present composition also exhibits excellent esthetic properties, such as copious foam and foam stability and may optionally contain ingredients to increase skin compatibility and skin health. Moreover, the composition may exhibit reduced tissue irritancy potential. [0014] A further aspect of the present invention is to provide personal use products based on an antimicrobial composition of the present invention, for example, a skin cleanser, a surgical scrub, a hand sanitizer gel, a disinfectant, antiseptic wash, and the like.
[0015] A further aspect of the present invention is to provide a method of reducing Gram positive and/or Gram negative bacteria populations on mammalian tissue, including human tissue, by contacting the tissue, like the dermis, with a composition of the present invention for a sufficient time, such as about 30 seconds to 5 minutes, to reduce the bacteria level to a desired level. Antimicrobial efficacy is applicable to viral and fungal organisms as well as Gram positive and Gram negative bacteria.
[0016] While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the detailed description is to be regarded as illustrative in nature and not restrictive.
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] FIG . 1 illustrates a graph depicting the tests results of the efficacy following a 30 second exposure time of three different cationic active ingredients, specifically, 0.5 % quat (benzalkonium chloride), 2% CHG (chlorhexidine gluconate), and 1% PHMB (polyhexamethylene biguanide) in a representative surfactant system.
[0018] FIG. 2 illustrates a graph depicting the test results of the efficacy against S. aureus and E. coli bacteria with increased concentrations of quaternary sugar-derived surfactants, specifically, poly (trimomumhydroxypropyl cocogluocosides chloride). The amount and type of cationic active ingredient (0.5% ADBAC) and foam boosting surfactant (1.95% alkyl dimethyl amine oxide) was held constant.
[0019] FIG. 3 illustrates a graph depicting the test results of the efficacy with increased concentrations of foam boosting surfactants, specifically, amine oxide. The amount and type of cationic active ingredient (0.5% ADBAC) and quaternary sugar- derived surfactant (1.25 % poly trimoniurnhydroxypropyl cocoglucosides chloride) were held constant.
[0020] FIG. 4 illustrates the dermal irritancy (mildness) of the preferred
embodiment for an antimicrobial dermal cleanser to four commercially available antimicrobial soaps.
[0021] FIG. 5 illustrates the foam profile of the preferred embodiment for an antimicrobial dermal cleanser to three commercially available antimicrobial soaps.
[0022] FIG. 6 illustrates the efficacy against S. aureus and E. coli bacteria following a 30 second exposure to a cationic active in combination with quaternary sugar-derived surfactants, held constant at 1.25% and an n-alkyl (C12-16) dimethylamine oxide foam boosting surfactant.
[0023] FIG. 7 illustrates the foam rigidity of the preferred embodiment for an antimicrobial dermal cleanser to two commercially available antimicrobial soaps with cationic actives.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0024] Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients or reaction conditions used herein are to be understood as being modified in all instances by the term "about".
[0025] As used herein, weight percent (wt-%), percent by weight, % by weight, and the like are synonyms that refer to the concentration of a substance as the weight of that substance divided by the total weight of the composition and multiplied by 100.
[0026] As used herein, the term "about" modifying the quantity of an ingredient in the compositions of the invention or employed in the methods of the invention refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the real world; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of the ingredients employed to make the
compositions or carry out the methods; and the like. The term about also encompasses amounts that differ due to different equilibrium conditions for a composition resulting from a particular initial mixture. Whether or not modified by the term "about," the claims include equivalents to the quantities.
[0027] As used herein, the term "cationic active" is defined as the ingredient that provides antimicrobial cidal activity.
[0028] As used herein, the term "skin care active" is defined as the ingredient or ingredients that improve or maintain the health of the dermal barrier.
[0029] The term "alkyl" refers to a straight or branched chain monovalent hydrocarbon radical having a specified number of carbon atoms. As used herein, "alkyl" refer to a linear or branched C6-Ci8 carbon chain.
[0030] The term "microbial" or "microbial population" refers to bacterial, fungal, yeast, or viral population or combinations thereof or any mixture thereof in a laboratory or natural setting.
[0031] The term "surfactant" or "surface active agent" refers to an organic chemical that when added to a liquid changes the properties of that liquid at a surface or interface.
[0032] "Cleansing" means to perform or aid in soil removal, bleaching, microbial population reduction, rinsing, or combination thereof.
[0033] As used herein, the term "substantially free" refers to compositions completely lacking the component or having such a small amount of the component that the component does not affect the effectiveness of the composition. The component may be present as an impurity or as a contaminant and shall be less than 0.5 wt. . In another embodiment, the amount of the component is less than 0.1 wt. % and in yet another embodiment, the amount of component is less than 0.01 wt. .
[0034] It should be noted that, as used in this specification and the appended claims, the singular forms "a", "an", and "the" include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a composition containing "a compound" includes a mixture of two or more compounds. It should also be noted that the term "or" is generally employed in its sense including "and/or" unless the content clearly dictates otherwise.
[0035] The term "actives" or "percent actives" or "percent by weight actives" or "actives concentration" are used interchangeably herein and refers to the concentration of those ingredients involved in cleansing expressed as a percentage minus inert ingredients usch as water or salts.
[0036] As used herein, the terms "triclosan free" or "free of triclosan" refers to a composition, mixture, or ingredients that do not contain triclosan (2,4,4' -trichloro- 2'hydroxy-diphenylether) or triclosan containing compounds or to which the same has not been added. Should triclosan or triclosan containing compounds be present through contamination of a composition, mixture, or ingredients, the amount of the same shall be less than 0.5 wt. . In another embodiment, the amount of is less than 0.1 wt. % and in yet another embodiment, the amount is less than 0.01 wt. .
Antimicrobial Compositions Containing Cationic Active Compounds and Quaternized Sugar Derived Surfactants
[0037] The present invention relates to an antimicrobial composition that exhibits fast efficacy and high foaming attributes. The antimicrobial composition comprises a cationic active ingredient, a quaternized sugar-derived surfactant, a foam boosting surfactant which may encompass anionic surfactants, nonionic surfactants, amphoteric surfactants, or cationic surfactants and water. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4'-trichloro-2'hydroxy- diphenylether),have a high cidal activity in a short amount of time, provide stable copious foam and may optionally contain ingredients to increase skin compatibility and skin health.
[0038] In one embodiment, an antimicrobial composition for reducing microbial population on dermal tissue includes: (a) about 0.3 wt.% to about 6.0 wt. , by weight of cationic actives; (b) about 0.1 wt.% to about 18 wt.%, by weight, of a quaternized sugar-derived surfactant; (c) about 0.1 wt.% to about 40 wt.%, by weight of a foam boosting surfactant; (d) about 1 wt.% to about 25 wt.% dermal adjuvants and (e) water or other suitable diluent. The relative weight ratio of cationic active ingredient to quaternized sugar surfactant to foam boosting surfactant is from about 1:0.2:0.2 to about 1:3:8.
[0039] Another aspect of the present invention is to provide an antimicrobial composition for reducing microbial population on dermal tissue which is stable and has a pH of about 5.0 to about 8.0. The present composition also surprisingly exhibits excellent esthetic properties, such as copious foam and foam stability and may optionally contain ingredients to increase skin compatibility and skin health. Moreover, the composition may exhibit reduced tissue irritancy potential.
[0040] A further aspect of the present invention is to provide personal use products based on an antimicrobial composition of the present invention, for example, a skin cleanser, a surgical scrub, a hand sanitizer gel, a disinfectant, and the like.
[0041] A further aspect of the present invention is to provide a method of reducing Gram positive and/or Gram negative bacteria populations on mammalian tissue, including human tissue, by contacting the tissue, like the dermis, with a composition of the present invention for a sufficient time, such as about 30 seconds to 5 minutes, to reduce the bacteria level to a desired level.
[0042] The following illustrates non-limiting embodiments of the present invention.
A. Cationic Actives
[0043] A cationic active is present in an antimicrobial composition for reducing microbial population on the dermal tissue of a mammal of the present invention in an amount of about 0.3 wt. % to about 6.0 wt. %, and preferably about 0.5 wt. % to about 5.0 wt.%, by weight of the composition.
[0044] The amount of antimicrobial agent in the composition is related to the end use of the composition, the amount of quaternized sugar-derived surfactant and foam boosting surfactant in the composition, and the presence of optional ingredients in the composition. The amount of antimicrobial agent is sufficient to achieve a microbial kill in a short contact time, for example, 15 to 30 seconds.
[0045] Cationic active ingredients are an antimicrobial agent useful in the present invention. The cationic or cationically-active ingredients are substances based on nitrogen centered cationic moieties with net positive change. The cationic or cationically-active ingredients are preferably selected from the group consisting of cationic polymers, cationic surfactants, cationic monomers, cationic silicon compounds, cationic derivatized protein hydrolyzates and betaine with at least one cationic or cationically-active group.
[0046] Suitable cationic active ingredients contain quaternary ammonium groups. Suitable cationic active ingredients especially include those of the general formula:
N(+)R1R2R3R4X(-) wherein R1, R2, R3 and R4 independently of each other represent alkyl groups, aliphatic groups, aromatic groups, alkoxy groups, polyoxyalkylene groups, alkylamido groups, hydroxyalkyl groups, aryl groups, H+ ions, each with from 1 to 22 carbon atoms, with the provison that at least one of the groups R1, R2, R3 and R4 has at least eight carbon atoms and wherein X(-) represents an anion, for example, a halogen, acetate, phosphate, nitrate or alkyl sulfate, preferably a chloride. The aliphatic groups can also contain cross-linking or other groups, for example additional amino groups, in addition to the carbon and hydrogen atoms.
[0047] Particular cationic active ingredients include, for example, but are not limited to, alkyl dimethyl benzyl ammonium chloride (ADBAC), alkyl dimethyl ethylbenzyl ammonium chloride, dialkyl dimethyl ammonium chloride, benzethonium chloride, N, N-bis-(3-aminopropyl) dodecylamine, chlorhexidine gluconate, PHMB (polyhexamethylene biguanide), salt of a biguanide, a substituted biguanide derivative, an organic salt of a quaternary ammonium containing compound or an inorganic salt of a quaternary ammonium containing compound or mixtures thereof. [0048] In accordance with an important feature of the present invention, a present antimicrobial composition is substantially free of triclosan. The phrase "substantially free" of triclosan is defined as meaning that the composition contains 0% to about 0.25% by weight, in total, of triclosan. In particular, triclosan may be present in an antimicrobial composition in a total amount of 0.25% or less either as a by-product or as a component of an ingredient in the composition, but triclosan is not intentionally introduced into the composition.
[0049] Triclosan is disfavored as an antimicrobial agent due to environmental and health concerns due to the possible formation of intermediate and/or environmental by products.
B. Quaternized Sugar-Derived Surfactant
[0050] In addition to an antimicrobial agent, the present antimicrobial composition for reducing microbial population on the dermal tissue of a mammal of the present invention also contains a quaternized sugar-derived surfactant. The quaternized sugar- derived surfactant is present in an amount of about 0.1% to about 18%, and preferably about 0.25% to about 12.5%, by weight, of the composition.
[0051] The amount of quaternized sugar-derived surfactant present in the composition is related to the amount of the cationic active in the composition, to the identity of the quaternized sugar-derived surfactant, and the end use of the composition.
[0052] The quaternized sugar-derived surfactant is a quaternized alkyl
polyglucoside or a polyquaternized alkyl polyglucoside, and the like.
[0053] In one embodiment, the antimicrobial composition of the present invention includes a polyquaternary functionalized alkyl polyglucoside, a cationic active ingredient, water, and an optional foam boosting surfactant. The poly quaternary functionalized alkyl polyglucoside is a cationic surfactant naturally derived from alkyl polyglucosides and has a sugar backbone. Poly quaternary alkyl polyglucosides have the following representative formula:
Figure imgf000012_0001
Wherein R is an alkyl group having from about 6 to about 22 carbon atoms and n is an integer ranging from 4 to 6. Examples of suitable poly quaternary functionalized alkyl polyglucosides components which can be used in the cleansing compositions according to the present invention include those in which the R alkyl moiety contains from about 8 to about 12-carbon atoms. In a preferred embodiment the quaternary functionalized alkyl polyglucoside contains primarily about 10-12 carbon atoms.
Examples of commercially suitable poly quaternary functionalized alkyl polyglucosides useful in cleansing compositions of the present invention include but is not limited to: Poly Suga Quat series of quaternary functionalized alkyl polyglucosides, available from Colonial Chemical, Inc., located in South Pittsburg, TN.
[0054] In another embodiment, the antimicrobial composition of the present invention includes a quaternary functionalized alkyl polyglucoside, a cationic active ingredient, water, and an optional foam boosting surfactant. The quaternary
functionalized alkyl polyglucoside is a naturally derived cationic surfactant from alkyl polyglucosides and has a sugar backbone. Quaternary functionalized alkyl
polyglucosides have the following representative formula:
[0055] Wherein Ri is an alkyl group having from about 6 to about 22 carbon atoms, and R2 is CH3(CH2 where n' is an integer ranging from 0-21. Examples of suitable quaternary functionalized alkyl polyglucosides components which can be used in the cleansing compositions according to the present invention include those in which the Ri alkyl moiety contains primarily about 10-12 carbon atoms, the R2 group is C¾ and n is the degree of polymerization of 1 -2. Further examples of a suitable quaternary functionalized alkyl polyglucoside include, but are not limited to, the antimicrobial and antifungal quaternary functionalized alkyl polyglucosides described in United States Patent numbers 7,084,129 and 7,507,399 the disclosures of which are hereby incorporated by reference. Examples of commercially suitable quaternary
functionalized alkyl polyglucosides useful in cleansing compositions of the present invention include but is not limited to: Suga Quat TM 1212 (primarily Ci2 quaternary functionalized alkyl polyglucoside), Suga Quat L 1210 (primarily Ci2 quaternary functionalized alkyl polyglucoside), and Suga Quat S 1218 (primarily Ci2 quaternary functionalized alkyl polyglucoside) available from Colonial Chemical, Inc., located in South Pittsburg, TN.
C. Foam-Boosting Co-Surfactant
[0056] In addition to an antimicrobial agent, and a quaternized sugar-derived surfactant the present antimicrobial composition for reducing microbial population on the dermal tissue of a mammal of the present invention also contains a foam boosting surfactant. The foam booting surfactant is present in an amount of about 0.02% to about 10.0%, and preferably about 2% to about 6%, by weight, of the composition.
[0057] The amount of foam boosting surfactant present in the composition is related to the amount of the cationic active in the composition, the amount of the quaternized sugar-derived surfactant in the composition, the identity of the foam boosting surfactant, and the end use of the composition.
[0058] The foam-boosting co-surfactant can be (a) nonionic surfactants, (b) amphoteric surfactants, (c) cationic surfactants, (d) anionic surfactants and the like, or (e) mixtures thereof.
Non Ionic Foam Boosting Surfactant
[0059] Examples of non ionic foam-boosting co-surfactants include, but are not limited to, alkyl amine oxide, alkyl ether amine oxide, alkyl alcohol alkoxylates, aryl alcohol alkoxylates, substituted alcohol alkoxylates, block nonionic copolymers, heteric nonionic copolymers, alkanolamides, substituted amides, or polyethoxylated glycerol derivatives.
[0060] The antimicrobial composition can contain a nonionic surfactant component that includes a detersive amount of nonionic surfactant or a mixture of nonionic surfactants. Typically, a nonionic surfactant has a hydrophobic region, such as a long chain alkyl group or an alkylated aryl group, and a hydrophilic group comprising an ethoxy and/or other hydrophilic moieties. As defined herein, a "nonionic foam-boosting co-surfactant" has a hydrophobic region having an alkyl group containing six to eighteen carbon atoms, and an average of one to about twenty ethoxy and/or propoxy moieties. Examples of non ionic foam-boosting co-surfactants include, but are not limited to, alkyl amine oxide, alkyl ether amine oxide, alkyl alcohol alkoxylates, aryl alcohol alkoxylates, substituted alcohol alkoxylates, block nonionic copolymers, heteric nonionic copolymers, alkanolamides, or polyethoxylated glycerol esters, and mixtures thereof. [0061] Numerous other nonionic surfactants are disclosed in McCutcheon's Detergents and Emulsifiers, 1993 Annuals, published by McCutcheon Division, MC Publishing Co., Glen Rock, N.J., pp. 1-246 and 266-273; in the CTFA International Cosmetic Ingredient Dictionary, Fourth Ed., Cosmetic, Toiletry and Fragrance
Association, Washington, D.C. (1991) (hereinafter the CTFA Dictionary) at pages 1- 651 ; and in the CTFA Cosmetic Ingredient Handbook, First Ed., Cosmetic, Toiletry and Fragrance Association, Washington, D.C. (1988) (hereafter the CTFA Handbook), at pages 86-94, each incorporated herein by reference.
Amphoteric Foam Boosting Surfactant
[0062] The antimicrobial composition can contain an amphoteric surfactant component that includes a detersive amount of amphoteric surfactant or a mixture of amphoteric surfactants. Suitable amphoteric surfactants that can ne used include, but are not limited to, imidiazolines and imidiazoline derivatives, isethionates, betaine derivatives, amphoacetate derivatives, propionates, and mixtures thereof.
Anionic Foam Boosting Surfactant
[0063] The antimicrobial composition can contain an anionic surfactant component that includes a detersive amount of an anionic surfactant or a mixture of anionic surfactants. The anionic surfactants that can be used according to the invention include any anionic surfactant available in the cleansing industry. Suitable groups of anionic surfactants include sulfonates and sulfates. Suitable surfactants that can be provided in the anionic surfactant component include, but are not limited to, sarcosine derivatives, succinic acid derivatives, carboxylated alcohols, alkyl sulfate and alkyl ether sulfates, sulfonic acid derivatives, diphenyll sulfonate derivatives, alkyl aryl sulfonic acid derivatives, alkyl polyglucoside sulfates or sulfonates.
Cationic Foam Boosting Surfactant
[0064] The antimicrobial composition may contain a cationic surfactant component that includes a detersive amount of cationic surfactant or a mixture of cationic surfactants. Cationic surfactants that can be used in the antimicrobial composition include, but are not limited to, quaternized polysaccharides, alkyl polysaccharides, alkoxylated amines, alkoxylated ether amines, phospholipids, phospholipid derivatives, and mixtures thereof.
D. Carrier
[0065] The carrier of the present antimicrobial composition comprises water, propylene glycol, glycerols, alcohols or mixtures thereof. It should be appreciated that the water may be provided as deionized water or as softened water. The water provided as part of the concentrate can be relatively free of hardness. It is expected that the water can be deionized to remove a portion of the dissolved solids. That is, the concentrate can be formulated with water that includes dissolved solids, and can be formulated with water that can be characterized as hard water.
[0066] The antimicrobial composition of the present invention does not rely upon a low pH or a high pH to provide a rapid reduction in microbial populations.
Antimicrobial populations of the present invention have a pH of about 5.0 to about 8.0. Within this pH range, the present compositions effectively reduce microbial populations, and are consumer acceptable, i.e., are mild to the skin, are phase stable, and generate copious, stable foam.
E. Additional Functional Materials
[0067] The antimicrobial composition can include additional components or agents, such as additional functional materials. As such, in some embodiments, the
antimicrobial composition including the cationic active ingredients and quaternary sugar-derived surfactants may provide a large amount, or even all of the total weight of the antimicrobial composition, for example, in embodiments having few or no additional functional materials disposed therein. The functional materials provide desired properties and functionalities to the antimicrobial composition. For the purpose of this application, the term "functional materials" include a material that when dispersed or dissolved in a use and/or concentrate solution, such as an aqueous solution, provides a beneficial property in a particular use. The antimicrobial composition containing the cationic active ingredients and the quaternized sugar-derived surfactants may optionally contain other disinfectants, sanitizers, dyes, thickening or gelling agents, and perfumes. Some particular examples of functional materials are discussed in more detail below, but it should be understood by those of skill in the art and others that the particular materials discussed are given by way of example only, and that a broad variety of other functional materials may be used. For example, may of the functional material discussed below relate to materials used in disinfecting and/or cleansing applications, but it should be understood that other embodiments may include functional materials for use in other applications.
Dyes and Fragrances
[0068] Various dyes, odorants including perfumes, and other aesthetic enhancing agents which are compatible with the invention chemistry may also be included in the antimicrobial composition.
[0069] Fragrances or perfumes that may be included in the compositions include, for example, terpenoids such as citronellol, aldehyes such as amyl cinnamaldehyde, a jasmine such as CIS-jasmine or jasmal, vanillin, and the like.
Adjuvants
[0070] The present composition can also include any number of adjuvants. In one embodiment adjuvants are present in an amount of about 1% to about 25%, and preferably about 1% to about 15 %, by weight, of the composition, Specifically, the antimicrobial composition can include glycerin, sorbitol, esters, polyquats, glycols, preservatives, chelators, pH additives, pigments or dyes among any number of other constituents which can be added to the composition. Such adjuvants can be pre- formulated with the present composition or added to the system simultaneously, or even after, the addition of the present composition. The antimicrobial composition can also contain any number of other constituents as necessitated by the application, which are known and which can facilitate the activity of the present invention. Embodiments of the Present Invention
[0071] The antimicrobial composition of the present invention has a high broad spectrum of antimicrobial efficacy, high foam and reduced irritation to mammalian tissue. Exemplary compositions are provided in the following tables.
Antimicrobial Dermal Cleanser
Table 1 -Antimicrobial Dermal Wash Exemplary Composition (Expressed as Weight Percentage)
Antimicrobial Dermal Wash (pH 5.0 - 6.7)
Preferred Embodiment Most Preferred (% w/w) Embodiment (% w/w)
Ingredient Example
Upper
Lower Limit Upper Limit Lower Limit Limit
Quaternary
Ammonium
Compound
Cationic Active (QAC) [AlkyI
0.4 1.5 0.5 1.0 Ingredient Dimethyl Benzyl
Ammonium
Chloride
(ADBAC)l
Quaternary
functionalized
alkyl
Quaternized Sugar- polyglucoside or
0.1 4.5 0.25 2.5 Derived Surfactant Polyquaternary
functionalized
alkyl
polyglucoside
Dimethyl amine
Foam Boosting
oxide; alkyl 0.1 12.0 1.0 5.0 Surfactant
polyglucoside
Glycerin, Sorbitol,
Esters,
Adjuvants (Dermal) Polyquats, 1.0 25.0 2.0 10.0
Glycols,
Preservative Table 2-Antimicrobial Dermal Wash Exemplary Composition (Expressed as Weight Ratio)
Figure imgf000019_0001
Table 3- Dermal Cleanser Exemplary Composition (Expressed as Weight Percentage)
Dermal Cleanser (pH 5.5 - 7.5)
Preferred Embodiment (% Most Preferred w/w) Embodiment (% w/w)
Ingredient Example
Upper
Lower Limit Upper Limit Lower Limit Limit
Quaternary
Ammonium
Compound (QAC)
Cationic Active [Alkyl Dimethyl
0.3 5.0 0.5 4.0 Ingredient Benzyl
Ammonium
Chloride
(ADBAC)]
Quaternary
functionalized
alkyl
Quaternized Sugar- polyglucoside or
0.1 15.0 0.25 10.0 Derived Surfactant Polyquaternary
functionalized
alkyl
polyglucoside Dimethyl amine
Foam Boosting
oxide; alkyl 0.1 40.0 2.0 20.0 Surfactant
polyglucoside
Glycerin, Sorbitol,
Esters,
Adjuvants (Dermal) 1 .0 25.0 1.75 15.0
Polyquats,
Preservative
Table 4- Dermal Cleanser Exemplary Composition (Expressed as Weight Ratio)
Figure imgf000020_0001
Table 5- Surgical Scrub Exemplary Composition (Expressed as Weight
Percentage)
Surgical Scrub (pH 5.5 - 7.5)
Preferred Embodiment (% Most Preferred w/w) Embodiment (% w/w)
Ingredient Example
Upper
Lower Limit Upper Limit Lower Limit Limit
Cationic Active Chlorhexidine
1 6.0 1.5 5.0 Ingredient Gluconate (CHG)
Quaternary
Quaternized Sugar- functionalized
0.2 18.0 0.6 12.5 Derived Surfactant alkyl
polyglucoside or Polyquaternary
functionalized
alkyl
polyglucoside
Dimethyl amine
Foam Boosting
oxide; alkyl 0.2 36.0 1.5 25.0 Surfactant
polyglucoside
Glycerin, Sorbitol,
Esters,
Adjuvants (Dermal) 1 .0 25.0 2.0 10.0
Polyquats,
Preservative
Table 6- Surgical Scrub Exemplary Composition (Expressed as Weight Ratio)
Figure imgf000021_0001
[0072] The formula may be available as a ready-to-use or concentrate which would be subsequently diluted to the proper use concentration with water either manually or by suitable equipment or an apparatus. The concentrate composition of the present invention can be provided as a solid, liquid, or gel, or a combination thereof. In one embodiment, the cleansing compositions may be provided as a concentrate such that the cleansing composition is substantially free of any added water or the concentrate may contain a nominal amount of water The concentrate can be formulated without any water or can be provided with a relatively small amount of water in order to reduce the expense of transporting the concentrate. For example, the composition concentrate can be provided as a capsule or pellet of compressed powder, solid, or loose powder, either contained by a water soluble material or not. In the case of providing the capsule or pellet of the composition in a material, the capsule or pellet can be introduced into a volume of water, and if present the water soluble material can solubilize, degrade, or disperse to allow contact of the composition concentrate with the water. For the purposes of this disclosure, the terms "capsule" and "pellet" are used for exemplary purposes and are not intended to limit the delivery mode of the invention to a particular shape.
[0073] When provided as a liquid concentrate composition, the concentrate can be diluted through dispensing equipment using aspirators, peristaltic pumps, gear pumps, mass flow meters, and the like. This liquid concentrate embodiment can also be delivered in bottles, jars, dosing bottles, bottles with dosing caps, and the like. The liquid concentrate composition can be filled into a multi-chambered cartridge insert that is then placed in a spray bottle or other delivery device filled with a pre-measured amount of water.
[0074] In yet another embodiment, the concentrate composition can be provided in a solid form that resists crumbling or other degradation until placed into a container. Such container may either be filled with water before placing the composition concentrate into the container, or it may be filled with water after the composition concentrate is placed into the container. In either case, the solid concentrate composition dissolves, solubilizes, or otherwise disintegrates upon contact with water. In a particular embodiment, the solid concentrate composition dissolves rapidly thereby allowing the concentrate composition to become a use composition and further allowing the end user to apply the use composition to a surface in need of cleansing. When the cleansing composition is provided as a solid, the compositions provided herein may be altered in a manner to solidify the cleansing composition by any means known in the art. For example, the amount of water may be reduced or additional ingredients may be added to the cleansing composition, such as a solidification agent. [0075] In another embodiment, the solid concentrate composition can be diluted through dispensing equipment whereby water is sprayed at the solid block forming the use solution. The water flow is delivered at a relatively constant rate using mechanical, electrical, or hydraulic controls and the like. The solid concentrate composition can also be diluted through dispensing equipment whereby water flows around the solid block, creating a use solution as the solid concentrate dissolves. The solid concentrate composition can also be diluted through pellet, tablet, powder and paste dispensers, and the like.
EXAMPLES
[0076] The present invention is more particularly described in the following examples that are intended as illustrations only, since numerous modifications and variations within the scope of the present invention will be apparent to those skilled in the art. Unless otherwise noted, all parts, percentages, and ratios reported in the following examples are on a weight basis, and all reagents used in the examples were obtained, or are available, from the chemical suppliers described below, or may be synthesized by conventional techniques.
[0077] Materials used in the described embodiments include, but are not limited to: Stearyldimonium-hydroxypropyl Laurylglucosides Chloride, Cocoglucosides
Hydroxypropyl-trimonium Chloride, Laurylglucosides Hydroxypropyl-trimonium Chloride, Poly (Lauryldimonium-hydroxypropyl Decylglucosides Chloride), Poly (Stearyldimonium-hydroxypropyl Decylglucosides Chloride), Poly (Stearyldimonium- hydroxypropyl Laruylglucosides Chloride), Poly (Trimonium-hydroxypropyl
Cocoglucosides Chloride).
[0078] The following methods were used in the preparation and testing of the examples:
Antimicrobial and Microbial Efficacy:
(a) Determination of Time Kill Activity: The activity of antimicrobial
compositions was measured by the time kill method [ASTM E 2315 Standard Guide for Assessment of Antimicrobial Activity Using a Time Kill Procedure], whereby the survival of challenged organisms exposed to an antimicrobial test composition is deterred as a function of time. In this test, a diluted aliquot of the composition is brought into contact with a known population of test bacteria for a specified time period at a specified temperature. The test composition is neutralized at the end of the time period, which arrests the antimicrobial activity of the composition. The percent or, alternatively, log reduction from the original bacteria population is calculated. In general, the time kill method is known to those skilled in the art. In addition, comparative data on the foam profile of representative systems is shown.
(b) The composition can be tested at any concentration from 0-100%. The choice of which concentration to use is at the discretion of the investigator, and suitable concentrations are readily determined by those skilled in the art. All testing if performed in triplicate, the results are combined, and the average log reduction is reported.
(c) The choice of contact time period also is at the discretion of the
investigator. Any contact time period can be chosen. Typical contact times range from 15 second to 5 minutes, with 30 seconds and 1 minute being typical contact times. The contact temperature also can be any
temperature, typically room temperature, or about 25 degrees Celsius.
(d) The microbial suspension, or test inoculum, is prepared by growing a
microbial culture on any appropriate solid media (e.g., agar). The microbial population then is washed from the agar with sterile
physiological saline and the population of the microbial suspension is adjusted to about 10 colony forming units per ml (cfu/ml).
(e) The table below lists the test microbial cultures used in the following tests and includes the name of the bacteria, the ATCC (American Type Culture Collection) identification number, and the abbreviation for the name organism used hereafter.
Figure imgf000025_0001
S. aureus is a Gram positive bacteria, whereas, E. coli is a Gram negative bacteria.
[0079] The log reduction is calculated using the formula:
Log reduction = logw (numbers control) - log w (test sample survivors). Foam Height Determination
[0080] The foam height was determined with the following procedural steps:
1.Prepare a 1 % solution of the product in 5 grain water.
2. Pour 150mL of the solution into a blender
3. Mix on medium speed 10 seconds.
4. Pour into a 1000 mL beaker and measure foam height.
5. Measure foam height at 3 and 5 minutes.
Foam Stability Determination
[0081] The foam stability was determined by using the difference between the foam/ air interference and the foam/aqueous interface 5 minutes after pouring a 1% solution into a lOOOmL beaker.
In Vitro Irritancy Determination
[0082] In vitro irritancy was assessed by an external testing facility using Matek Corporation's "EpiDerm MTT ET-50 Protocol (EPI-200)". [0083] The test consists of a topical exposure of the neat test chemical to a reconstructed human epidermis (RhE) model followed by a cell viability test. Cell viability is measured by dehydrogenase conversion of MTT [(3-4,5-dimethyl thiazole 2- yl) 2,5-diphenyltetrazolium bromide], present in cell mitochondria, into a blue formazan salt that is quantitatively measured after extraction from tissues. The reduction of the viability of tissues exposed to chemicals in comparison to negative controls (treated with water) is used to predict the skin irritation potential.
[0084] EpiDerm tissues are conditioned by incubation ot release transport-stress related compounds and debris overnight. After pre-incubation, tissues are topically exposed to the test chemicals for 60 minutes. Preferably, three tissues are used per test chemical (TC) and for the positive control (PC) and negative control (NC). Tissues are then thoroughly rinsed, blotted to remove the test substances, and transferred to fresh medium. Tissues are incubated for 42 hrs. Afterwards, the MTT assay is performed by transferring the tissues to 24-well plates containing MTT medium (1 mg/mL) after a 3 hr MTT incubation, the blue formazan salt formed by cellular mitochondria is extracted with 2.0 mL/tissue of isopropanol and the optical density of the extracted formazan is determined using a spectrophotometer at 570nm. Relative cell viability is calculated for each tissue as % of the mean of the negative control tissues. Skin irritation potential of the test material is predicted if the remaining relative cell viability is below 50%.
Foam Resistance Determination
[0085] The foam resistance was determined by measuring 65 grams of the test product into a blender and blending for about 10 seconds on medium speed. Thereafter, the test solution was poured into a cylinder and a plastic ball was dropped into the test solution and timed to determine how many seconds it took for the plastic ball to drop from a first pre-determined level to a second pre-determined level, e.g., from 100 mL mark on the cylinder to the 40 mL mark on the cylinder.
[0086] The following Figures demonstrate efficacy data of the present antimicrobial composition, using various cationic active ingredients, quaternary sugar-derived surfactants and optional foam boosting surfactants. [0087] Table 7 and Figure 1 (Log Kill of Cationic Active Ingredients): The following figures illustrate the efficacy following a 30 second exposure time of three different cationic active ingredients, specifically, 0.5 % Quat (Benzalkonium Chloride), 2% CHG (Chlorhexidine Gluconate), and 1% PHMB (polyhexamethylene biguanide) in a representative surfactant system.
[0088] Table 7 illustrates the formulas for the three cationic active ingredient systems tested. Both the quaternary sugar-derived surfactant and foam boosting surfactant were held constant and only the cationic active ingredient was changed between the three tests performed. The results are illustrated in Figure 1.
Figure imgf000027_0001
TABLE 7
[0089] As illustrated in Figure 1 , all three cationic active ingredients had high cidal activity against S. aureus and E. coli bacteria within a 30 second exposure time.
[0090] Table 8 and Figure 2 (Log Kill of Quaternary Sugar-Derived Surfactants): Next, Applicants tested the efficacy against S. aureus and E. coli bacteria with increased concentrations of quaternary sugar-derived surfactants, specifically, Poly
(Trimoniumhydroxypropyl Cocogluocosides Chloride). The amount and type of cationic active ingredient (0.5% ADBAC Quat) and foam boosting surfactant (1.95% Alkyl Dimethyl Amine Oxide) was held constant. Table 8 below illustrates the quantitative results of this test and Figure 2 illustrates the graphical results.
Quaternized Active Foam S. aureus Log E. coli Log
Figure imgf000028_0001
TABLE 8
[0091] As Table 8 and Figure 2 illustrate, the quaternary sugar-derived surfactant has a high cidal activity against S. aureus and E. coli bacteria after only 30 seconds of exposure. Also, the tolerance of the quaternary sugar derived surfactant against bacteria is shown. Furthermore, it is clearly illustrated that an increased concentration of quaternary sugar-derived surfactant maintains a good log kill of bacteria up until a 1 to 4 ratio of quaternary sugar-derived surfactant to cationic active ingredients.
[0092] Table 9 and Figure 3 (Log Kill of Foam Boosting Surfactants): Table 15 and Figure 3 illustrate the efficacy with increased concentrations of foam boosting surfactants, specifically, amine oxide. The amount and type of cationic active ingredient (0.5% ADBAC Quat) and Quaternary sugar-derived surfactant (1.25 % Poly
Trimomumhydroxypropyl Cocoglucosides Chloride) were held constant. Table 9 below illustrates the quantitative results of this test and Figure 3 illustrates the graphical results.
Figure imgf000028_0002
TABLE 9
[0093] As Table 9 and Figure 3 illustrate, the foam boosting surfactant has a high cidal activity against S. aureus and E. coli bacteria after only 30 seconds of exposure. Also, the tolerance of the foam boosting surfactant against bacteria is shown. Furthermore, it is clearly illustrated that a broad range of foam boosting surfactant maintains a good log kill of bacteria.
[0094] Figure 4 (Mildness Index for an Antimicrobial Dermal Cleanser
Embodiment): Applicants tested the dermal irritancy (mildness) of the preferred embodiment for an antimicrobial Dermal Cleanser as illustrated in Table 12 to four commercially available antimicrobial soaps. Commercially Available Products A, C and D are available by Gojo Medicated, Akron, Ohio and Commercially Available Product B is available by Dial a subsidiary of Henkel Corporation, Dusseldorf, Germany. As illustrated in Figure 4, the antimicrobial dermal cleanser of the current invention has a high relative mildness index especially in comparison to antimicrobial hand soaps that are commercially available.
[0095] Figure 5 (Foam Profile for an Antimicrobial Dermal Cleanser Embodiment): Applicants tested the foam profile of the preferred embodiment for an antimicrobial Dermal Cleanser as illustrated in Table 12 to three commercially available antimicrobial soaps. As illustrated in Figure 6, the antimicrobial dermal cleanser of the current invention has both good foam volume and foam stability especially in comparison to antimicrobial hand soaps that are commercially available.
[0096] Table 10 and Figure 6 (Efficacy of Cationic Actives in Combination with Quaternary Sugar Derived Surfactants and Alkyl Dimethyl Amine Oxide): Applicants tested the efficacy against S. aureus and E. coli bacteria with various quaternary sugar- derived surfactants, held constant at 1.25%. The amount and type of cationic active ingredient (0.5% ADBAC Quat) and foam boosting surfactant (1.95% Alkyl Dimethyl Amine Oxide) was held constant.
Quaternized
Active Foam Boosting
Sugar-Derived S. aureus Log E. coli Log
Ingredient (% Surfactant
Surfactant Reduction Reduction w/w) (% w/w)
(1.25 % w/w)
(L8610)
Lauridimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0 Cocoglucosides
Chloride (L1210)
Lauridimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0
Laurylglucosides
Chloride
(S 1218)
Stearyldimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0 Laurylglucosides
Chloride
(TM8610)
Cocoglucosides
Hydroxypropyl- 0.5 1.95 >5.0 >5.0 trimonium
Chloride
(TM1212)
Laurylglucosides
Hydroxypropyl- 0.5 1.95 >5.0 >5.0 trimonium
Chloride
(L1010P)
Poly
(Lauryldimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0 Decylglucosides
Chloride)
(S 1010P)
Poly
(S tearyldimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0 Decylglucosides
Chloride)
(S 1210P)
Poly
(S tearyldimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0 Laruylglucosides
Chloride)
(TM8610P)
Poly (Trimonium- hydroxypropyl 0.5 1.95 >5.0 >5.0
Cocoglucosides
Chloride)
TABLE 10
[0097] As Table 10 illustrates, a high log kill is maintained against S. aureus and E. coli bacteria for both quaternized sugar-derived surfactants and polyquaternized sugar- derived surfactants. The chain length of the sugar quaternary surfactant may be altered and yet still maintain high efficacy. The graphical results of the test are illustrated in Figure 6.
[0098] Table 1 1 and Figure 7 (Comparative Foam Rigidity): Applicants tested the foam rigidity of an embodiment of the current invention for use in dermal applications as shown below in Table 1 1 in comparison to two commercially available products, Commercial Products E and F. Commercial Products E and F are traditional anionic surfactant base dermal washes containing a cationic active. Commercial Product E is commercially available by Proctor & Gamble, Cincinnati, Ohio and Commercial Product F is commercially available by Deb Group Limited, United Kingdom, England. The results of the foam rigidity test are illustrated in Figure 7. As illustrated in Figure 7, the foam rigidity of the dermal wash of the current invention is greater than
commercially available cationic active dermal washes with a traditional anionic surfactant base.
Foam Rigidity Formula of Current Invention (pH of 5.5-7.5):
Figure imgf000031_0001
TABLE 11
[0099] Table 12 (Antimicrobial Efficacy of a Dermal Cleanser of the Current Invention): Applicants tested the efficacy of the dermal cleanser of the current invention by determining the log reduction of both gram positive and gram negative bacterial after 30 seconds of exposure. Dermal Cleanser of Current Invention (pH of 5.5-7.5):
Component Weight Percent Range
Water 7.5 - 99.3
Cationic Active (Quaternary Ammonium 0.3 - 5
Compound)
Quaternized Sugar-Derived Surfactant 0.05 - 7.5
Foam Boosting Surfactant 0.2 - 5
Dermal Adjuvants 0.1 - 7
TABLE 12
Table 13(Antimicrobial Efficacy of a Surgical Scrub of the Current Invention):
Applicants tested the efficacy of the surgical scrub of the current invention by determining the log reduction of both gram positive and gram negative bacterial after 30 seconds of exposure.
Surgical Scrub of Current Invention (pH of 5.5-7.5):
Component Weight Percent Range
Water 56 - 97.8
Cationic Active (Quaternary 1 - 6
Ammonium Compound)
Quaternized Sugar-Derived Surfactant 0.2 - 8
Foam Boosting Surfactant 0.5 - 10
Dermal Adjuvants 0.5 - 20
TABLE 13
[00100] The antimicrobial compositions of the present invention have several practical end uses, including hand cleansers, surgical scrubs, hand sanitizer gels, and similar personal care products. Additional types of compositions include foamed compositions, such as creams, mousses, and the like. The present antimicrobial compositions can be manufactured as dilute ready-to-use compositions, or as concentrates that are diluted prior to use.
[00101] Obviously, many modifications and variations of the invention as hereinbefore set forth can be made without departing from the spirit and scope thereof, and, therefore, only such limitations should be imposed as are indicated by the appended claims.

Claims

We Claim:
1. An antimicrobial dermal cleanser comprising:
(a) a cationic active ingredient;
(b) a quaternized sugar-derived surfactant;
(c) a foam boosting surfactant; and
(d) water.
2. The antimicrobial composition of claim 1 , wherein the composition comprises about 0.3 wt. % to about 6 wt. % cationic active ingredients.
3. The antimicrobial composition of claim 1, wherein the cationic active ingredient is selected from the group comprising of: a salt of a biguanide, a substituted biguanide derivative, an organic salt of a quaternary ammonium containing compound or an inorganic salt of a quaternary ammonium containing compound.
4. The antimicrobial composition of claim 1 , wherein the composition comprises about 0.1 wt. % to about 18 wt. % quaternized sugar-derived surfactant.
5. The antimicrobial composition of claim 1, wherein the quaternized sugar derived surfactant is a quaternized alkyl polyglucoside or a polyquaternized alkyl polyglucoside.
6. The antimicrobial composition of claim 1 , wherein the composition comprises about 0.1 wt.% to about 40 wt.% foam boosting surfactants.
7. The antimicrobial composition of claim 1, wherein the foam boosting surfactant is selected from the group comprising of: nonionic surfactants, amphoteric surfactants, anionic surfactants, or cationic surfactants.
8. The antimicrobial composition of claim 7, wherein the nonionic surfactants comprise of alkyl amine oxide, alkyl ether amine oxide, alkyl alcohol alkoxylates, aryl alcohol alkoxylates, substituted alcohol alkoxylates, block nonionic copolymers, heteric nonionic copolymers, alkanolamides, or polyethoxylated glycerol esters.
9. The antimicrobial composition of claim 7, wherein the amphoteric surfactants comprise of imidiazohnes and imidiazoline derivatives, isethionates, betaine deriatives, or amphoacetate derivatives.
10. The antimicrobial composition of claim 7, wherein the anionic surfactants comprise of sarcosine derivatives, succinic acid derivatives, carboxylated alcohols, alkyl sulfate and alkyl ether sulfates, sulfonic acid derivatives or diphenyl sulfonate derivatives or alkyl aryl sulfonic acid derivatives.
11. The antimicrobial composition of claim 7, wherein the cationic surfactants comprise of quaternized polysaccharide, alkyl poly saccharides, alkoxylated amines, alkoxylated ether amine, phospholipids and phospholipid derivatives.
12. The antimicrobial composition of claim 1, wherein the composition has a pH range from about 4.0 to about 9.0.
13. The antimicrobial composition of claim 1, wherein the composition further comprises about 1 wt. % to about 25 wt.% adjuvants such as glycerin, sorbitol esters, polyquats or preservatives.
14. The antimicrobial composition of claim 1, wherein the composition exhibits high cidal activity.
15. The antimicrobial composition of claim 1, wherein the composition provides copious foam and foam stability.
16. The antimicrobial composition of claim 1, wherein the composition improves skin compatibility and skin health.
17. The antimicrobial composition of claim 1, wherein the composition exhibits reduced tissue irritancy potential.
18. The antimicrobial composition of claim 1, wherein the composition is free of triclosan (2,4,4"-trichloro-2"-hydroxy-diphenylether).
19. The antimicrobial composition of claim 1, wherein the relative weight ratio of cationic active ingredient to quaternized sugar surfactant to foam boosting surfactant is from about 1:0.2:0.2 to about 1 :3:8.
20. A method of reducing bacterial, microbial, fungicidal or viral population on a dermal tissue of a mammal comprising the step of contacting the dermal tissue of a mammal with the composition of claim 1 for a sufficient time to provide substantial bacterial, microbial, fungicidal or viral reduction.
21. The method of claim 20 wherein the sufficient contact time is approximately about 1 to about 60 seconds.
22. The method of claim 20 wherein the composition of claim 1 is rinsed off of a dermal tissue of a mammal after contact or remains on the dermal tissue of a mammal after contact.
23. A method of reducing bacterial, microbial, fungicidal or viral population on a dermal tissue of a mammal by contacting the dermal tissue with an antimicrobial composition for a sufficient time to provide substantial bacterial, microbial, fungicidal or viral reduction, the antimicrobial composition comprising: (a) a cationic active ingredient;
(b) a quaternized sugar-derived surfactant;
(c) a foam boosting surfactant; and
(d) water.
24. The method of claim 23, wherein the composition comprises about 0.3 wt. % to about 6.0 wt. % cationic active ingredients.
25. The method of claim 23, wherein the cationic active ingredient is selected from the group comprising of: a salt of a biguanide, a substituted biguanide derivative, an organic salt of a quaternary ammonium containing compound or an inorganic salt of a quaternary ammonium containing compound.
26. The method of claim 23, wherein the composition comprises about 0.1 wt. % to about 18 wt.% quaternized sugar-derived surfactant.
27. The method of claim 23, wherein the quaternized sugar derived surfactant is a quaternized alkyl polyglucoside or a polyquaternized alkyl polyglucoside.
28. The method of claim 23, wherein the composition comprises about 0.1 wt.% to about 40 wt.% foam boosting surfactants.
29. The method of claim 23, wherein the foam boosting surfactant is selected from the group comprising of: nonionic surfactants, amphoteric surfactants, anionic surfactants, or cationic surfactants.
30. The foam boosting surfactant of claim 29, wherein the nonionic surfactants comprise of alkyl amine oxide, alkyl ether amine oxide, alkyl alcohol alkoxylates, aryl alcohol alkoxylates, substituted alcohol alkoxylates, block nonionic copolymers, heteric nonionic copolymers, alkanolamides, or polyethoxylated glycerol esters.
31. The foam boosting surfactant of claim 29, wherein the amphoteric surfactants comprise of imidiazohnes and imidiazoline derivatives, isethionates, betaine deriatives, or amphoacetate derivatives.
32. The foam boosting surfactant of claim 29, wherein the anionic surfactants comprise of sarcosine derivatives, succinic acid derivatives, carboxylated alcohols, alkyl sulfate and alkyl ether sulfates, sulfonic acid derivatives or diphenyl sulfonate derivatives or alkyl aryl sulfonic acid derivatives.
33. The foam boosting surfactant of claim 29, wherein the cationic surfactants comprise of quaternized polysaccharide, alkyl poly saccharides, alkoxylated amines, alkoxylated ether amine, phospholipids and phospholipid derivatives.
34. The method of claim 23, wherein the composition has a pH range from about 4.0 to about 9.0.
35. The method of claim 23, wherein the composition further comprises about 1 wt. % to about 25 wt.% adjuvants such as glycerin, sorbitol esters, polyquats or
preservatives.
36. The method of claim 23, wherein the composition exhibits high cidal activity.
37. The method of claim 23, wherein the composition provides copious foam and foam stability.
38. The method of claim 23, wherein the composition improves skin compatibility and skin health.
39. The method of claim 23, wherein the composition exhibits reduced tissue irritancy potential.
40. The method of claim 23, wherein the composition is free of triclosan (2,4,4"- trichloro-2' '-hydr oxy-diphenylether) .
41. The method of claim 23, wherein the relative weight ratio of cationic active ingredient to quaternized sugar surfactant to foam boosting surfactant is from about 1:0.2:0.2 to about 1:3:8.
42. The method of claim 23 wherein the sufficient contact time is approximately about 1 to about 60 seconds.
43. The method of claim 23 wherein the composition is rinsed off of a dermal tissue of a mammal after contact or remains on the dermal tissue of a mammal after contact.
PCT/IB2011/054157 2010-09-22 2011-09-22 Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants WO2012038914A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201180045325.6A CN103118655B (en) 2010-09-22 2011-09-22 Antimicrobial compositions containing the surfactant that cationic active ingredients and quaternary sugar derive
JP2013528829A JP5990174B2 (en) 2010-09-22 2011-09-22 Antibacterial composition comprising a cationic active ingredient and a surfactant derived from a quaternary sugar
BR112013006096-4A BR112013006096B1 (en) 2010-09-22 2011-09-22 ANTIMICROBIAN COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUARTER SUGAR DERIVATIVES
MX2013003141A MX2013003141A (en) 2010-09-22 2011-09-22 Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants.
EP11826498.5A EP2618806B1 (en) 2010-09-22 2011-09-22 Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38534110P 2010-09-22 2010-09-22
US61/385,341 2010-09-22

Publications (2)

Publication Number Publication Date
WO2012038914A2 true WO2012038914A2 (en) 2012-03-29
WO2012038914A3 WO2012038914A3 (en) 2012-08-02

Family

ID=45817932

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/IB2011/054158 WO2012038915A2 (en) 2010-09-22 2011-09-22 Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants
PCT/IB2011/054157 WO2012038914A2 (en) 2010-09-22 2011-09-22 Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/054158 WO2012038915A2 (en) 2010-09-22 2011-09-22 Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants

Country Status (7)

Country Link
US (4) US9095134B2 (en)
EP (3) EP2618807B1 (en)
JP (4) JP5932802B2 (en)
CN (2) CN103118655B (en)
BR (2) BR112013006096B1 (en)
MX (2) MX2013003141A (en)
WO (2) WO2012038915A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105107421A (en) * 2015-09-17 2015-12-02 湖州新奥特医药化工有限公司 Acetic acid mixer structure
US10440950B2 (en) 2015-09-17 2019-10-15 Ecolab Usa Inc. Methods of making triamine solids
US10463041B2 (en) 2015-09-17 2019-11-05 Ecolab Usa Inc. Triamine solidification using diacids
US10517806B2 (en) 2014-08-01 2019-12-31 Ecolab Usa Inc. Antimicrobial foaming compositions containing cationic active ingredients
US11590065B2 (en) 2014-03-25 2023-02-28 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329633B2 (en) * 2010-09-22 2012-12-11 Ecolab Usa Inc. Poly quaternary functionalized alkyl polyglucosides for enhanced food soil removal
US8389457B2 (en) * 2010-09-22 2013-03-05 Ecolab Usa Inc. Quaternary functionalized alkyl polyglucosides for enhanced food soil removal
US9095134B2 (en) * 2010-09-22 2015-08-04 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants
US8877703B2 (en) 2010-09-22 2014-11-04 Ecolab Usa Inc. Stearyl and lauryl dimoniumhydroxy alkyl polyglucosides for enhanced food soil removal
US9232790B2 (en) * 2011-08-02 2016-01-12 Kimberly-Clark Worldwide, Inc. Antimicrobial cleansing compositions
EP2866557B1 (en) 2012-06-29 2018-08-22 Ecolab USA Inc. Glycerin ether ethoxylate solfactants
EP2919862B1 (en) * 2012-11-16 2016-09-14 Colgate-Palmolive Company Cleansing composition with an alkoxylated alkyl ether
US9393252B2 (en) 2013-03-12 2016-07-19 Ecolab Usa Inc. Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses
US9808435B2 (en) 2013-03-12 2017-11-07 Ecolab Usa Inc. Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
US9226941B2 (en) * 2013-03-12 2016-01-05 Patrick C. Cooksey Two-component cleaning and disinfecting system
US9636286B2 (en) 2013-06-19 2017-05-02 Coloplast A/S Antimicrobial cleanser
US10435652B2 (en) 2014-02-14 2019-10-08 Lonza Ltd. Liquid laundry detergent composition for clothing
US20150252310A1 (en) 2014-03-07 2015-09-10 Ecolab Usa Inc. Alkyl amides for enhanced food soil removal and asphalt dissolution
AU2014392694B2 (en) 2014-04-30 2020-07-02 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of skin aging
US11260020B2 (en) 2014-04-30 2022-03-01 Kimberly-Clark Worldwide, Inc. Topical compositions and methods for reducing oxidative stress
BR112016023571B1 (en) 2014-04-30 2020-12-01 Kimberly-Clark Worldwide, Inc. methods to reduce the signs of skin aging in an individual, to increase the adipogenesis of an individual's face and body and to increase the lipogenesis of an individual's face and body
US10646430B2 (en) 2014-04-30 2020-05-12 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
US9546933B2 (en) * 2014-07-30 2017-01-17 The Boeing Company Determining aerosol material compatibility
JP6904979B2 (en) 2016-03-01 2021-07-21 エコラボ ユーエスエー インコーポレイティド Sterilized rinse based on the synergistic effect of quaternary anionic surfactant
US10799433B2 (en) 2016-04-20 2020-10-13 S. C. Johnson & Son, Inc. Foaming antimicrobial compositions
EP3496540A4 (en) * 2016-08-11 2020-07-15 Ecolab USA Inc. Interaction between antimicrobial quaternary compounds and anionic surfactants
US10308897B2 (en) 2017-04-24 2019-06-04 Gpcp Ip Holdings Llc Alkaline sanitizing soap preparations containing quaternary ammonium chloride agents
MX2019012494A (en) * 2017-06-08 2019-12-02 Huntsman Petrochemical Llc Polyphenylmethanol surfactants.
SG11202001163UA (en) 2017-08-30 2020-03-30 Ecolab Usa Inc Molecules having one hydrophobic group and two identical hydrophilic ionic groups and compositions thereof
CN107753310A (en) * 2017-09-04 2018-03-06 广州市拓瑞化工科技有限公司 A kind of gentle three-in-one washing lotion of the non-stimulated antibacterial cleaning-nursing of women privates and preparation method thereof of new type of safe
WO2019210041A1 (en) * 2018-04-27 2019-10-31 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
US11084974B2 (en) 2018-08-29 2021-08-10 Championx Usa Inc. Use of multiple charged cationic compounds derived from polyamines for clay stabilization in oil and gas operations
US11685709B2 (en) 2018-08-29 2023-06-27 Ecolab Usa Inc. Multiple charged ionic compounds derived from polyamines and compositions thereof and use thereof as reverse emulsion breakers in oil and gas operations
AU2019332961B2 (en) 2018-08-29 2022-04-07 Ecolab Usa Inc. Multiple charged ionic compounds derived from polyamines and compositions thereof and methods of preparation thereof
WO2020047015A1 (en) 2018-08-29 2020-03-05 Ecolab Usa Inc. Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system
WO2020047181A1 (en) 2018-08-29 2020-03-05 Ecolab Usa Inc. Use of multiple charged ionic compounds derived from polyamines for waste water clarification
EP3897143A1 (en) * 2019-01-29 2021-10-27 Ecolab USA Inc. Use of cationic sugar-based compounds for microbial fouling control in a water system
US11155480B2 (en) * 2019-01-29 2021-10-26 Ecolab Usa Inc. Use of cationic sugar-based compounds as corrosion inhibitors in a water system
JP2020128354A (en) * 2019-02-08 2020-08-27 吉田製薬株式会社 Disinfection agent
WO2020214196A1 (en) 2019-04-16 2020-10-22 Ecolab Usa Inc. Use of multiple charged cationic compounds derived from polyamines and compositions thereof for corrosion inhibition in a water system
US11889832B2 (en) 2019-05-17 2024-02-06 Ecolab Usa Inc. Antimicrobial enhancement of cationic active skin antiseptics
US20220264886A1 (en) * 2021-02-19 2022-08-25 Zoono Group Ltd Kill and Protect Surface Disinfectant and Hand Sanitizer for Combatting Contact Infection Spread
CN113057929B (en) * 2021-04-02 2023-03-17 河南邦瑞特实业有限公司 Hand-washing-free disinfection gel
WO2022251186A1 (en) * 2021-05-27 2022-12-01 Arkema Inc. Storage stable latex-silicate dispersion
CN113880451B (en) * 2021-10-14 2023-06-09 广州阿美新材料有限公司 Glass scratch-resistant protection liquid and use method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215461A1 (en) 1997-05-20 2005-09-29 Novapharm Research (Australia) Pty. Ltd. Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism
US7084129B1 (en) 2003-09-15 2006-08-01 Colonial Chemical Antimicrobial quaternary surfactants based upon alkyl polyglycoside
US20090069436A1 (en) 2004-08-05 2009-03-12 Ebiox, Ltd. Antimicrobial skin composition comprising a biguanide or a quaternium compound
US7507399B1 (en) 2004-08-05 2009-03-24 Surfatech Corporation Functionalized polymeric surfactants based upon alkyl polyglycosides
WO2010033562A2 (en) 2008-09-22 2010-03-25 Bausch & Lomb Incorporated Lens care solutions comprising alkyldimonium hydroxypropyl alkylglucosides

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567174A (en) 1984-05-07 1986-01-28 Imperial Chemical Industries Plc Bis(1-substituted biguanide) derivatives
US5234618A (en) 1989-10-09 1993-08-10 Kao Corporation Liquid detergent composition
CA2064664C (en) 1991-04-05 2000-01-11 Hiroshi Ishikawa Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives
JP2962856B2 (en) * 1991-04-26 1999-10-12 花王株式会社 Detergent composition
US5188756A (en) 1991-08-07 1993-02-23 Kolmar Laboratories, Inc. Topical cleansing and conditioning composition
US5415814A (en) 1993-08-27 1995-05-16 The Procter & Gamble Company Concentrated liquid or gel light duty dishwashing detergent composition containing calcium xylene sulfonate
US5417893A (en) 1993-08-27 1995-05-23 The Procter & Gamble Company Concentrated liquid or gel light duty dishwashing detergent compositions containing calcium ions and disulfonate surfactants
DE4413686C2 (en) * 1994-04-20 1996-10-24 Henkel Kgaa Cationic sugar surfactants, process for their preparation and their use
US5653970A (en) 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US5707959A (en) 1995-05-31 1998-01-13 The Procter & Gamble Company Processes for making a granular detergent composition containing a crystalline builder
MX9707912A (en) * 1996-02-14 1997-11-29 Stepan Co Reduced residue hard surface cleaner comprising hydrotrope.
US5756446A (en) 1996-05-07 1998-05-26 Henkel Corporation Sugar surfactants having enhanced tactile properties
JPH10330793A (en) * 1997-06-04 1998-12-15 Lion Corp Agent for enhancing bactericidal power, enhancing of bactericidal power, and bactericidal detergent composition
US6057274A (en) 1997-08-22 2000-05-02 Henkel Corporation Antibacterial composition having enhanced tactile properties
SE511873C2 (en) * 1997-08-27 1999-12-13 Akzo Nobel Nv Cationic sugar surfactants from ethoxylated ammonium compounds and reducing saccharides and their use as surfactants for surfactants
CO5040174A1 (en) 1997-12-12 2001-05-29 Colgate Palmolive Co ANTIMICROBIAL COMPOSITIONS FOR MULTIPLE MICROEMULSION PURPOSES CONTAINING A CATIONIC TENSIOACTIVE
JP3548533B2 (en) 1999-01-28 2004-07-28 キヤノン株式会社 Electron beam equipment
US6221828B1 (en) 1999-02-12 2001-04-24 Kao Corporation Detergent composition comprising an alkylpolyglycoside, a germicide, and a fatty acid salt
JP3299951B2 (en) * 1999-02-12 2002-07-08 花王株式会社 Washing soap
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6369021B1 (en) 1999-05-07 2002-04-09 Ecolab Inc. Detergent composition and method for removing soil
US6130196A (en) 1999-06-29 2000-10-10 Colgate-Palmolive Co. Antimicrobial multi purpose containing a cationic surfactant
DE19933404A1 (en) 1999-07-21 2001-01-25 Henkel Kgaa Use of sugar surfactant(s) to adjust the viscosity of an aqueous surfactant-containing medium to give a thickened medium for disinfecting and/or cleaning sanitary surfaces
US6559116B1 (en) 1999-09-27 2003-05-06 The Procter & Gamble Company Antimicrobial compositions for hard surfaces
US6140289A (en) 2000-01-24 2000-10-31 Colgate-Palmolive Company Antimicrobial cleaning composition containing a cationic surfactant
US6846492B2 (en) 2000-02-23 2005-01-25 Ciba Specialty Chemicals Corporation Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces
US20030074742A1 (en) 2000-03-03 2003-04-24 General Electric Company Siloxane dry cleaning composition and process
US6764989B1 (en) 2000-10-02 2004-07-20 Huish Detergents, Inc. Liquid cleaning composition containing α-sulfofatty acid ester
US7345015B1 (en) 2006-12-19 2008-03-18 The Clorox Company Low residue cleaning solution for disinfecting wipes comprising a C8-10 alkyl polyglycoside
US20020183233A1 (en) 2000-12-14 2002-12-05 The Clorox Company, Delaware Corporation Bactericidal cleaning wipe
US6395691B1 (en) 2001-02-28 2002-05-28 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Personal wash compositions containing particle-in-oil dispersion
GB0105342D0 (en) * 2001-03-03 2001-04-18 Selden Res Ltd Biocidal cleaning composition
JP4230153B2 (en) 2002-02-22 2009-02-25 花王株式会社 Antifouling cleaner for hard surfaces
TWI271434B (en) 2002-02-22 2007-01-21 Kao Corp Antifouling detergent for hard surfaces
US20050176614A1 (en) 2002-10-16 2005-08-11 Heinz-Dieter Soldanski Transparent abrasive cleaning product, especially manual dishwashing liquid
US20040136940A1 (en) 2002-10-31 2004-07-15 Virginia Lazarowitz Cleaner compositions
JP2004224703A (en) * 2003-01-20 2004-08-12 Teepol Diversey Kk Sterilizing detergent composition for finger
US7250392B1 (en) 2003-03-07 2007-07-31 Cognis Corporation Surfactant blend for cleansing wipes
KR20060010736A (en) 2003-04-14 2006-02-02 가오가부시끼가이샤 Cleaning agent composition
JP3980514B2 (en) * 2003-04-17 2007-09-26 花王株式会社 Disinfectant cleaning composition
US20050000030A1 (en) 2003-06-27 2005-01-06 Dupont Jeffrey Scott Fabric care compositions for lipophilic fluid systems
JP4050676B2 (en) 2003-08-22 2008-02-20 花王株式会社 Cleaning fee
US6774096B1 (en) * 2003-10-09 2004-08-10 Colgate-Palmolive Co. Zinc oxide containing surfactant solution
US6846786B1 (en) 2003-10-09 2005-01-25 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Process for making low surfactant, high sugar bars
US6881710B1 (en) 2004-03-04 2005-04-19 Colonial Chemical Inc. Personal care products based upon surfactants based upon alkyl polyglucoside quaternary compounds
JP2006028115A (en) * 2004-07-20 2006-02-02 Shiseido Co Ltd Antimicrobial agent
US6906023B1 (en) 2004-08-18 2005-06-14 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Soap bars comprising high levels of sugars made by extrusion route
US6906018B1 (en) 2004-08-18 2005-06-14 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Extrudable soap bars comprising high levels of sugars
WO2006042316A1 (en) 2004-10-12 2006-04-20 Pantheon Chemical, Inc Composition for cleaning and degreasing, system for using the composition, and methods of forming and using the composition
DE102004051420A1 (en) 2004-10-22 2006-05-04 Merz Pharma Gmbh & Co. Kgaa Propulsion gas-free foamable preparation, useful e.g. as sun protection preparation and cosmetic agent, comprises carbohydrate (preferably e.g. sugar esters) and co-surfactant of non-ionic ethoxylated/propoxylated surfactant
KR101292027B1 (en) 2005-05-23 2013-08-05 다우 코닝 코포레이션 Surface treatment compositions comprising saccharide-siloxane copolymers
US7179779B1 (en) 2006-01-06 2007-02-20 North Carolina State University Cationic bleach activator with enhanced hydrolytic stability
WO2007101445A1 (en) * 2006-03-08 2007-09-13 Glad, Thomas Christian Biocidal cleaning compositions
US7897553B2 (en) 2006-10-23 2011-03-01 Bausch & Lomb Incorporated Biguanide composition with low terminal amine
DE102007039649A1 (en) 2006-12-05 2008-06-12 Henkel Kgaa Cleaning agent for hard surfaces
TW200826840A (en) 2006-12-28 2008-07-01 Compal Electronics Inc Quaternary ammonium salt anti-bacterial and water-borne coating material having antibiotic property containing the same
US20090005281A1 (en) * 2007-03-26 2009-01-01 Hutton Iii Howard David Compositions Containing Amine Oxide Surfactants or Soil Penetration Agents
JP5252826B2 (en) * 2007-04-17 2013-07-31 ディバーシー株式会社 Cleaning composition for hard surface
WO2009029046A1 (en) 2007-08-29 2009-03-05 Agency For Science, Technology And Research Sugar-based surfactant microemulsions containing essential oils for cosmetic and pharmaceutical use
US9095134B2 (en) * 2010-09-22 2015-08-04 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants
US9232790B2 (en) 2011-08-02 2016-01-12 Kimberly-Clark Worldwide, Inc. Antimicrobial cleansing compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215461A1 (en) 1997-05-20 2005-09-29 Novapharm Research (Australia) Pty. Ltd. Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism
US7084129B1 (en) 2003-09-15 2006-08-01 Colonial Chemical Antimicrobial quaternary surfactants based upon alkyl polyglycoside
US20090069436A1 (en) 2004-08-05 2009-03-12 Ebiox, Ltd. Antimicrobial skin composition comprising a biguanide or a quaternium compound
US7507399B1 (en) 2004-08-05 2009-03-24 Surfatech Corporation Functionalized polymeric surfactants based upon alkyl polyglycosides
WO2010033562A2 (en) 2008-09-22 2010-03-25 Bausch & Lomb Incorporated Lens care solutions comprising alkyldimonium hydroxypropyl alkylglucosides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Cosmetic, Toiletry and Fragrance Association", 1991, CTFA DICTIONARY, article "CTFA International Cosmetic Ingredient Dictionary", pages: 1 - 651
"CTFA Cosmetic Ingredient Handbook", 1988, COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION, article "CTFA Cosmetic Ingredient Handbook", pages: 86 - 94
"McCutcheon's Detergents and Emulsifiers, 1993 Annuals", 1993, MCCUTCHEON DIVISION, MC PUBLISHING CO., pages: 1 - 246,266-273
See also references of EP2618806A4

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590065B2 (en) 2014-03-25 2023-02-28 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients
US10517806B2 (en) 2014-08-01 2019-12-31 Ecolab Usa Inc. Antimicrobial foaming compositions containing cationic active ingredients
CN105107421A (en) * 2015-09-17 2015-12-02 湖州新奥特医药化工有限公司 Acetic acid mixer structure
CN105107421B (en) * 2015-09-17 2017-06-23 湖州新奥特医药化工有限公司 A kind of acetic acid mixer structure
US10440950B2 (en) 2015-09-17 2019-10-15 Ecolab Usa Inc. Methods of making triamine solids
US10463041B2 (en) 2015-09-17 2019-11-05 Ecolab Usa Inc. Triamine solidification using diacids
US11051512B2 (en) 2015-09-17 2021-07-06 Ecolab Usa Inc. Triamine solidification using diacids
US11730167B2 (en) 2015-09-17 2023-08-22 Ecolab Usa Inc. Triamine solidification using diacids

Also Published As

Publication number Publication date
CN103118656B (en) 2015-09-16
US8933055B2 (en) 2015-01-13
US10624826B2 (en) 2020-04-21
JP2017155053A (en) 2017-09-07
US9474703B2 (en) 2016-10-25
JP6154935B2 (en) 2017-06-28
EP3461334A1 (en) 2019-04-03
WO2012038915A3 (en) 2012-08-02
EP2618807A2 (en) 2013-07-31
EP2618807A4 (en) 2014-03-05
US20120071438A1 (en) 2012-03-22
JP2014500887A (en) 2014-01-16
CN103118655A (en) 2013-05-22
BR112013006091B1 (en) 2018-07-31
US20150087717A1 (en) 2015-03-26
BR112013006091A2 (en) 2017-09-19
BR112013006096B1 (en) 2018-07-10
WO2012038915A2 (en) 2012-03-29
BR112013006096A2 (en) 2017-09-19
JP2014502954A (en) 2014-02-06
JP2016155856A (en) 2016-09-01
EP2618806A2 (en) 2013-07-31
EP2618807B1 (en) 2020-03-11
EP2618806A4 (en) 2014-03-05
MX2013003142A (en) 2013-05-30
CN103118656A (en) 2013-05-22
WO2012038914A3 (en) 2012-08-02
MX2013003141A (en) 2013-05-30
JP5990174B2 (en) 2016-09-07
CN103118655B (en) 2015-12-09
EP2618806B1 (en) 2020-03-25
US9095134B2 (en) 2015-08-04
JP5932802B2 (en) 2016-06-08
US20120070341A1 (en) 2012-03-22
US20150290100A1 (en) 2015-10-15

Similar Documents

Publication Publication Date Title
US10624826B2 (en) Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants
US20230157937A1 (en) Antimicrobial compositions containing cationic active ingredients
US6204230B1 (en) Antibacterial compositions containing a solvent, hydrotrope, and surfactant
AU2018214102A1 (en) Antimicrobial foaming compositions containing cationic active ingredients
US20030125224A1 (en) Compositions having enhanced deposition of a topically active compound on a surface
WO2002076207A1 (en) Antibacterial compositions
CN108125812B (en) A kind of antibacterial foam liquid soap of amino acid pattern and preparation method thereof
WO2000078141A1 (en) Antibacterial compositions
JP2000273489A (en) Composition for cosmetic and cleansing preservation liquid
CN112515996B (en) Antibacterial hand sanitizer and preparation method thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180045325.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11826498

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2013528829

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/003141

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011826498

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013006096

Country of ref document: BR

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: 112013006096

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013006096

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130314